TW200533300A - Composition for inhibting dietary lipid absorption - Google Patents

Composition for inhibting dietary lipid absorption Download PDF

Info

Publication number
TW200533300A
TW200533300A TW094102271A TW94102271A TW200533300A TW 200533300 A TW200533300 A TW 200533300A TW 094102271 A TW094102271 A TW 094102271A TW 94102271 A TW94102271 A TW 94102271A TW 200533300 A TW200533300 A TW 200533300A
Authority
TW
Taiwan
Prior art keywords
composition
absorption
fat
group
gum
Prior art date
Application number
TW094102271A
Other languages
Chinese (zh)
Inventor
Tsuneyuki Noda
Takao Saito
Syoichiro Inoue
Noriyuki Kouda
Takuya Kishimoto
Hiroshi Okamatsu
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of TW200533300A publication Critical patent/TW200533300A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/722Chitin, chitosan
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/732Pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics

Abstract

It is intended to provide a composition having an excellent effect of inhibiting lipid absorption which can inhibit the absorption of lipids taken by meals and contribute to the efficient discharge of the lipids from the body. This composition is characterized by containing (1) chitosan and (2) at least one water-soluble dietary fiber selected from the group consisting of guar gum, pectin, tara gum and locust bean gum.

Description

200533300 九、發明說明: 【發明所屬之技術領域;j 技術領域 本發明係關於一種組成物,其可阻礙飲食中所含脂肪 5之吸收,因而可期待其抗高血脂症及抗肥胖等之作用。200533300 IX. Description of the invention: [Technical field to which the invention belongs; j TECHNICAL FIELD The present invention relates to a composition that can hinder the absorption of fat 5 contained in the diet, so it can be expected to have antihyperlipidemia and antiobesity effects. .

Γ «tr J 發明背景 背景技術 10 15 近年,伴隨飲食生活之歐美化,日本人之脂肪(特別a 動物性麟)攝取量逐日增加。依據細2年之目民營養調: 結果(厚生勞動省),來自脂肪之熱量所佔熱量攝取量之比: (即,脂肪熱量比)於_歲年齡層中,超過係成人之適」 比率上限之25%。 喝§ 脂肪攝取量之增加佐 化症、冠狀動脈疾病=與肥胖、循環系統疾維動脈硬 尿病等之發病相關。錢梗塞及職塞等)及糖 犯朴更是引起循環系統疾病'呼 統疾病及糖尿病等各藉八y 了及糸 該等疾病發病錢衫f之危險因子。即使是由預防 領域中之重《題。料之及治療亦成為醫療 如前述,抑制或卩大 以及隨後之各種合併症7肪過嶋取、伴隨而來之肥胖 之方雖食叫^知有控制飲食 劑以控制食欲之方法(率代°°之方法、投予食欲抑制 取熱量之、_方法=^ )収透過運動來提高所插 1運動療法)等。實際上,這些方法也卫 20 200533300 被採用以作為肥胖對策。 然而’飲食療法大多是強行過度之限制飲食,而難以 長時間實行此種療法。而關於攝取脂肪替代品之方法,雖 然現在正在開發各種脂肪替代品,但任何脂肪替代品均無 5法令人滿意(特別是在口味方面),因此,此方法在實施上相 當困難。作為藥物療法採用之食欲抑制劑則已知有如氣苯 咪吲哚(mazindol,Ciba-Geigy-NOVARTIS社,商品名:「薩 諾雷克斯(Sanorex™)」)、氟苯丙胺(fenfluramine,商品名: 「膨即明(Pondimin™)」,Wyeth-Ayerst Laboratories)等。然 10而,該等藥物僅能於醫師之指導下利用。此外,該等藥物 已有報告指出其多種副作用。因此,此種藥物療法伴有危 險性(參照非專利文獻1)。運動療法係透過過剩之運動以消 費熱量者。該方法與飲食療法併用可期待良好之效果。但 是,必須要在受到管理之嚴密計畫下長期持續,實施上仍 15 伴隨著困難。 如鈾所述,對患者而言,迄今用以作為肥胖對策之方 法均難以實施。而,為了取代上述肥胖對策,目前正在研 究及開發勒新之機能性製劑乃至於飲食品,即使在攝取過 剩脂肪時,其亦可達成使脂肪不蓄積在體内之作用(阻礙脂 20 肪吸收之作用或促進脂肪排泄之作用)。 透過此種研究及開發而被發現之機能性製劑或飲食品 之代表例可列舉如利用幾丁聚醣之製品。用於該製品之幾 丁聚醋具有阻礙脂肪蓄積之作用,而該製品可有效作為脂 肪蓄積阻礙劑一事已冗載於如非專利文獻2及3、專利文獻 200533300 1-4等。此外,亦有報告指出幾丁聚醣與葡甘露聚糖 (Glucomannan)併用可達到降低膽固醇之作用(參照非專利 文獻4)。 【非專利文獻 1】Hadler· A· J·: J· Clin. Pharm·,12, 453 (1972); 5 Stunkar. D. A.? et al.? Lancet, 1, 503 (1973). 【非專利文獻2】Nagyvary,J,J.: Nutr. Rep_ Int.,20, 677 (1977). 【非專利文獻3 】I· Ikeda: J. Nutr·,119,1383 (1989). 【非專利文獻 4 】Cynthia M. Gallaher,et al·, "Cholesterol Reduction by Glucomannan and Chitosan Is Mediated by Changes in Cholesterol 10 Absorption and Bile Acid and Fat Excretion in Rats,ff Journal of Nutrition 130:2753-2759 (2000). 【專利文獻1】特開平6-7117號公報 【專利文獻2】特開平1M47828號公報 【專利文獻3】特開200M69753號公報 15【專利文獻4】特開2003_113089號公報 然而,該等文獻所載之機能性製劑或飲食品均尚未能 在實用上達到充分之效果,相關業界仍望開發出具有更優 異之具脂肪蓄積阻礙作用或脂肪吸收阻礙作用之機能性製 劑或飲食品。 20 【屬^月内溶1】 發明之揭示 發明欲解決之課題 因此’本發明之目的在於提供一種與習知之利用幾丁 聚醣之機能性製劑及飲食品相較下,可達成更優異之脂肪 200533300 蓄積阻礙作用(脂肪吸收阻礙作用)之組成物(機能性製劑及 飲食品)。 此外,本發明之目的也在於提供一種透過投予或攝取 該組成物來阻礙膳食脂肪吸收之方法。 5 解決課題之手段 本案發明人為解決前述課題而反覆精心研究,結果發 現,將幾丁聚醣與關華豆膠、果膠、刺雲實膠或刺槐豆膠 組合而成之組成物中,幾丁聚醣所具有之脂肪蓄積阻礙作 用明顯提高,因而可提供一種符合前述目的而業經改善之 10可阻礙膳食性脂肪吸收之組成物(機能性製劑及飲食品)。 即,獲知若透過該組成物之經口攝取,將可顯著阻礙膳食 脂肪之吸收。本發明即係以此種真知灼見為基礎,更反覆 精心研究而終至完成者。 本發明可提供下述第1-8項所列舉之用以阻礙膳食脂 15 肪之組成物。 第1項一種用以阻礙膳食脂肪吸收之組成物,含有: (1)幾丁聚醣;及(2)水溶性食物纖維,係選自於由關華豆膠 (Guar Gum)、果膠(pectin)、刺雲實膠(Tara 〇臟)及刺槐豆 膠(Locust Bean Gum)所構成群組中之至少丨種。 20 帛2項如第1項之用以阻礙膳食脂肪吸收之組成物, 其中该水溶性食物纖維係選自於由關華豆膠、果膠及刺槐 豆膠所構成群組中之至少丨種。 第3項如第1項之用以阻礙膳食脂肪吸收之組成物, 其中該水溶性食物纖維為關華豆膠。 200533300 第4員如第1項之用以阻礙膳食脂肪 其相對於所含(1)幾丁聚醣丨重量份,係以1 之、、且成物, 含有⑺水溶性食物纖維,且該水溶性食物比例 :ι華種豆膠、果膠、刺雲實膠及刺槐豆膠所構成群 10 15 第5員纟第1項之用以阻礙腾食脂肪吸 其相對於所含⑴幾丁細重量份,係以^重^成物’ 含有(2)水溶性食物纖維’且該水溶性食物纖維:;:比例 關華豆膠、果膠及刺槐豆膠所構成群組中之至少^於由 弟6項人如弟3項之用以阻礙腾食脂肪吸收之組成物, 其相對於所3(1)幾丁聚醣1重量份’係以3-7重量份之比例 含有(2)關華豆膠。 第7項如第1〜6項中任一項之用以阻礙腾食脂肪吸收 之組成物,其係呈現-適於經口投予之形態。 第8員如第1〜6項中任一項之用以阻礙膳食脂肪吸收 之組成物,其係具有-飲食品形態,域飲食品之形態係 選自於由點心、飲料以及補給品(suppi_nt)所構成之群 組0 此外本^明可提供下述第9_17項所列舉之阻礙膳食 20 性脂肪吸收之方法。 第9項-種於需要阻礙膳食脂肪吸收之人體内阻礙 膳食脂肪吸收之方法,係使該人體經口攝取有效量之第1〜8 項中任一項之組成物者。 第10項—種於需要膳食脂肪排出體外之人體中使膳 200533300 食脂肪排出體外之方法,係使該人體經口攝取有效量之第 1〜8項中任一項之組成物者。 第11項一種對需要抗肥胖之人體之抗肥胖方法,係 使該人體經口攝取有效量之第1〜8項中任一項之組成物者。 5 第12項一種於脂肪攝取量較多之人體中抑制飲食後 血清三酸甘油脂上升之方法,其係使該人體經口攝取有效 量之第1-8項中任一項之組成物者。 第13項一種第1〜8項中任一項之組成物之用途,係使 該組成物用以阻礙膳食脂肪吸收者。 10 第14項一種第1〜8項中任一項之組成物之用途,係使 該組成物用以使膳食脂肪排出體外者。 第15項一種第1〜8項中任一項之組成物之用途,係使 該組成物用以抗肥胖者。 第16項一種第1-8項中任一項之組成物之用途,其係 15 用以抑制飲食後之血清三酸甘油脂上升者。 第17項一種(1)幾丁聚醣及(2)水溶性食物纖維之用 途,係使該等用以製造第1〜8項中任一項之組成物者,其中 該水溶性食物纖維係選自由關華豆膠、果膠、刺雲實膠及 刺槐豆膠所構成之群組中之至少1種。 20 本發明之組成物可達成非常優異之脂肪吸收阻礙作 用。該脂肪吸收阻礙作用與單獨使用幾丁聚醣時相較下格 外優異。即,本發明係發現幾丁聚醣與前述特定水溶性食 物纖維之組合在脂肪吸收阻礙作用上可發揮相乘效果,進 而得以完成者。 10 200533300 本發明中,可與幾丁聚醣併用之水溶性食物纖維係選 自於由關華豆膠、果膠、刺雲實膠及刺槐豆膠所構成之群 組者。該等之中,(a)宜選自於由關華豆膠、果膠及刺槐豆 膠所構成群組中之至少1種。而特別適宜與幾丁聚醣併用之 5水溶性食物纖維為(b)關華豆膠。 本發明之組成物中,作為有效成分加以利用之各成分 均已知係於食品領域中作為食品素材及食品添加物等,甚 易取得。舉例言之,使螃蟹及蝦等之甲殼類動物的甲殼施 加酸處理而獲得之幾丁質(chitin),即結合有N-乙醯基_D_ 10葡糖胺與D-葡糖胺之多糖類進行鹼處理,可獲得作為(1)成 分之幾丁聚酶。該幾丁聚醣亦為一種以聚葡糖胺為成分之 不浴性食物纖維,可依定法而調製出。欲更簡便時,可藉 商業手法取得。 本發明組成物中之前述(1)成分之含量在可達成本發明 六文果之纟下並無特別限制。通常,於組成物重量%中 係含0.1重量%以上,且宜含〇 2〜8〇重量%,而更宜含〇 2〜5〇 重量%。 本發明中’與前述(1)成分併用之構成(2)成分之各物質 句τ隶屬於水/谷性食物纖維(water_s〇iubie dietary fiber, 2〇 SDF) ’ 一般而言’於食品領域中係作為飲食品添加物(增黏 安定劑)使用。 更°羊口之’關華豆膠係以豆科之關華豆樹叩仍以 ⑽)種子為原料,從胚芽粹取後被製出,而以結 合有葡萄糖與甘露糖之多糖類為主成份(約含78〜82%半乳 11 200533300 甘露聚糖)。本發明之關華豆膠中,亦包含以酵素(如半纖維 分解酶(hemicellulase)、半乳甘露聚糖酶(galact〇maimanase) 等)將該關華豆膠加以分解處理而成之關華豆膠酶分解物。 果膠係一種形成植物組織之骨架構成成分之多糖類, 5 可由各種植物粹取而調製出。其基本上係由業經曱基化之 半乳糖醛酸(galactouronicacid)的結合體所構成。果膠可大 致分為水溶性之果膠酯酸;業與其他多糖類、蛋白質、無 機質等結合之不溶性原果膠(protopectin);以及可將原果膠 分解之果膠酸。本發明可使用該等中之任一者。構成果膠 10之經甲基化之半乳糖醛酸之甲基酯化度已知為約〇〜8〇%, 本發明可使用其中之任何曱基酯化度者。 刺雲實膠為由彌猴桃科刺雲樹妨α cd/osa Z·)種 子之胚芽粹取而調製出之種子多糖類。 刺槐豆膠係由刺槐樹《⑽)種子之胚芽粹 15取而調製出之多糖類(含有約88%之半乳甘露聚糖)。 該等物質可如前述般,由含有其等之各種植物中按照 定法調製出,為求簡便可藉商業手法取得。該等中之(2)成 :可單獨使用1種或將2種以上組合,再與前述(丨)成分之幾 丁聚醣併用。 2 0 | 本發明之用以阻礙膳食脂肪吸收之組成物中所含前述 (2)成分之量於可達成本發明效果之前提下並未受到特別限 制。通常,其配合量相對於本發明組成物所含之前述(1)成 刀1重量份,關華豆膠、果膠、刺雲實膠及刺槐豆膠之總量 係於Mo重量份之範圍,且宜於3_7重量份之範圍,更宜為5 12 200533300 重量份左右之量。 藉著將前述(1)成分與前述(2)成分組合使用,特別是於 前述之特定配合比例下組合使用,所得之組成物中之(1)成 分與(2)成分將互為相乘作用,而可發揮優異之阻礙脂肪吸 5 收效果。 此外,本發明組成物中,作有效成分之(1)成分及(2)成 分均有在日本國内作為食品及食品添加物之使用紀錄,安 全性亦受到確認,為可連續使用之素材。因此,將該等組 合配合而成之本發明之用以阻礙膳食脂肪吸收之組成物係 10 經口攝取(投予)無害,而可持續使用。 本發明之用以阻礙膳食脂肪吸收之組成物的重點在於 含有前述(1)成分及(2)成分作必須成分,但無須僅由該等成 分構成,在不損及本發明組成物原本之膳食脂肪吸收阻礙 作用及其他作用的前提下,更可為了將該組成物調製成可 15 容易經口攝取或投藥之形態,而含有食品衛生上可接受之 可食性成分或製劑學上可接受之成分來作為輔助成分。 除前述(1)成分及(2)成分以外,本發明組成物中,用以 作為可依需要而包含之補助成分之食品衛生上可接受的可 食性成分除糖類、脂肪及蛋白質等三大營養素以外,亦包 2〇 含一般已知係利用於调製飲食品之食品素材及食品添加物 等。更詳言之,該食品素材及食品添加物包含:天然甜味 劑(糖類以外)及合成甜味劑等甜味劑;維生素類及礦物質類 (電解質及微量元素);天然香料及合成香料等之著香劑;著 色劑;保存劑;天然果汁、天然果肉等。 13 200533300 此外,前述輔助成分之製劍學上可接受之成分包含醫 某u口邊域中已知係用於調製經㈡投予之製劑,如職形劑(填 充劑)、增1劑、結合劑、賦濕劑、崩解劑、滑澤劑、增黎 劑及界面活性劑等。可依所欲調製之製劑投予單位型態而 5 適當地由該等中選出。 本^明組成物可利用前述(1)成分、⑺成分及依需要之 ,、他輔助成刀而按照定法調製成口服組成物。口服級成物 匕a 口服用之邊藥品、類醫藥品及飲食品。且較佳為飲食 10 15 20 口口敲艮口口包含:具有阻礙膳食性脂肪之吸收作用的機 能性食品及特定保健用食品等。 本毛明之用以阻礙膳食脂肪吸收之組成物可採取 藥品或類醫藥品之形態僅需為可經口服利用者即可,並夫 受到特殊限制。該形態包含如_、丸劑、粉劑、 懸濁劑、乳劑、顆粒劑、膠囊劑、膠劑、糖漿及。 調製成該等形態之調製方法可依一般醫療用醫 之調製方法進行。 X貝请縻口口 食”==:礙膳食脂肪吸收之組成物所具有之飲 =悲並未洲_制,可尊如:(A)乳飲 困飲料、清涼飲料、石炭酸飲料、果汁飲料、蔬菜飲料、蔬 果汁飲料、綠飲料、酒精飲料、★啡飲料、紅茶飲料、 綠茶、混合茶、粉城料、_飲料、伽⑽等之飲料 形態’·⑻卡士達布丁、舒笑蕾(souffle)布丁、果汁布丁等 之布丁類、果凌、奶絲、優格等之點心類;(C)冰淇淋、 牛奶冰、淡奶冰(Lact0-ice)、匈冰、冰棒等冰品;⑼軟糖(包 14 200533300 含牛奶糖、牛軋糖、QQ糖、棉花糖等)以及硬果(包含太妃 糖等)等之糖果類;(E)硬餅乾(hard biscuit)、甜餅乾 (cookie)、薄脆餅(cracker)、柿麻糲、煎餅、榖類棒及牛軋 棒等之條狀點心類以及經使用擠壓器之膨化點心類等的點 5心形態;(F)麵包、蔬菜麵包等之麵包形態;(G)榖類等之榖 類形態;(H)清湯、濃湯等之湯(汁)形態;⑴魚板、香腸等 之填充製品形態;(J)調理咖喱等之調理包食品形態;(K) 烏龍麵、涼麵、細麵、驀麥麵、中華麵、米粉、春雨麵、 餛飩、義大利麵及通心麵等之麵形態;其他如丸劑、錠 10劑、顆粒劑、散劑、凍劑、膠囊劑等形態之補給品(輔助食 品);(M)單純流體食品、高營養之濃厚流體食品等之口服 流動食品等。該等之中,較佳之飲食品可列舉如:(A)飲料 形態、(E)點心形態及(L)補給品。 具有前述各種飲食品形態之本發明之用以阻礙膳食脂 15肪吸收之組成物除宜將(1)成分及(2)成分以前述比例配合 外,亦可依所需飲食品形態於調製上所慣用之處方及製造 方法進行製造。 此外’本發明之用以阻礙膳食脂肪吸收之組成物於將 其調製成飲料形態等之液狀形態時,雖無特殊限制,但宜 20調製成黏度在1〜3000mpa · s(較宜10〜l〇〇〇mpa · s,而更宜 50〜500mPa · s)之範圍内(測定黏度時採用之條件:使用Γ «tr J BACKGROUND OF THE INVENTION BACKGROUND OF THE INVENTION In recent years, with the westernization of dietary life in Japan, the intake of fat (especially an animal-like lin) in Japanese has increased day by day. Based on the nutritional adjustment for 2 years: the result (Ministry of Health, Labour and Welfare), the ratio of calories from fat to calorie intake: (ie, fat-to-calorie ratio) in the age group of _, is more suitable for adults "ratio 25% of the upper limit. Drinking § Increased fat intake is associated with morbidity, coronary artery disease = associated with the onset of obesity, circulatory system diseases, and arteriosclerosis. Money infarction and occupational congestion, etc.) and sugar guilty of puerpera are risk factors that cause circulatory system diseases, systemic diseases, and diabetes. Even by the weight of the problem in the field of prevention. The treatment of materials has also become a medical treatment. As mentioned above, the method of inhibiting or increasing the subsequent comorbidities and the accompanying obesity is accompanied by obesity. It is known that there are methods to control diet to control appetite (rate generation °° method, administration of appetite suppression to take calories, _method = ^) to improve the inserted 1 exercise therapy through exercise) and so on. In fact, these methods are also adopted as countermeasures for obesity. However, 'diet therapy' mostly restricts the diet excessively, and it is difficult to implement such therapy for a long time. Regarding the method of ingesting fat substitutes, although various fat substitutes are currently being developed, none of the fat substitutes is satisfactory (especially in terms of taste), so this method is quite difficult to implement. Known as appetite suppressants used in drug therapy are mazindol (Ciba-Geigy-NOVARTIS, trade name: "Sanorex ™"), fenfluramine (trade name) : "Pondimin ™", Wyeth-Ayerst Laboratories), etc. However, these drugs can only be used under the guidance of a physician. In addition, these drugs have been reported to have multiple side effects. Therefore, this type of drug therapy is associated with danger (see Non-Patent Document 1). Exercise therapy is the person who consumes calories through excess exercise. This method can be used in combination with diet therapy to obtain good results. However, it must be sustained for a long time under a strict management plan, and implementation is still accompanied by difficulties. As stated by uranium, the methods used to date as countermeasures for obesity have been difficult for patients to implement. In order to replace the obesity countermeasures mentioned above, currently researching and developing new functional preparations and even food and beverages, even when ingesting excess fat, it can also achieve the function of preventing fat from accumulating in the body (preventing the absorption of 20 fats) Effect or promote fat excretion). Typical examples of functional preparations or foods and drinks found through such research and development include products using chitosan. Chitosan used for this product has the effect of inhibiting fat accumulation, and the fact that this product can effectively act as a fat accumulation inhibitor has been redundantly described in Non-Patent Documents 2 and 3, Patent Documents 200533300 1-4, and the like. In addition, there have been reports that chitosan and Glucomannan can be used to reduce cholesterol (see Non-Patent Document 4). [Non-Patent Literature 1] Hadler · A · J: J · Clin. Pharm ·, 12, 453 (1972); 5 Stunkar. DA? Et al.? Lancet, 1, 503 (1973). [Non-Patent Literature 2 】 Nagyvary, J, J .: Nutr. Rep_ Int., 20, 677 (1977). [Non-Patent Document 3] I · Ikeda: J. Nutr ·, 119,1383 (1989). [Non-Patent Document 4] Cynthia M. Gallaher, et al., &Quot; Cholesterol Reduction by Glucomannan and Chitosan Is Mediated by Changes in Cholesterol 10 Absorption and Bile Acid and Fat Excretion in Rats, ff Journal of Nutrition 130: 2753-2759 (2000). [Patent Document 1 ] JP 6-7117 [Patent Document 2] JP 1M47828 [Patent Document 3] JP 200M69753 15 [Patent Document 4] JP 2003_113089 However, the functional preparations contained in these documents Neither the food nor the food or drink has yet to achieve a sufficient effect in practice. The related industry still hopes to develop a functional preparation or food and drink that has a better effect of inhibiting fat accumulation or inhibiting fat absorption. 20 [Belonging to dissolving in the month 1] Disclosure of the invention The problem to be solved by the invention Therefore, the purpose of the present invention is to provide a functional preparation and food and drink which use chitosan, which can achieve better results than the conventional ones Fat 200533300 Compositions (functional preparations and food and beverages) that inhibit accumulation (fat absorption). It is another object of the present invention to provide a method for inhibiting dietary fat absorption by administering or ingesting the composition. 5 Means to Solve the Problem The inventor of this case has repeatedly studied carefully in order to solve the foregoing problems. As a result, it has been found that in a composition composed of chitosan and Guanhua bean gum, pectin, jacaranda, or locust bean gum, several Butan has a significantly increased fat accumulation inhibiting effect, so it can provide a composition (functional preparations and food and drink) that can improve the absorption of dietary fat in accordance with the aforementioned purpose and has been improved. That is, it was found that if the composition is taken orally, the absorption of dietary fat can be significantly hindered. The present invention is based on such insights, and iteratively researched and completed them. The present invention can provide the composition for blocking dietary fat as listed in items 1 to 8 below. Item 1 A composition for hindering the absorption of dietary fat, comprising: (1) chitosan; and (2) a water-soluble dietary fiber selected from the group consisting of Guar Gum, pectin ( pectin), Tara viscera, and Locust Bean Gum. 20 帛 2 The composition for hindering the absorption of dietary fat according to item 1, wherein the water-soluble dietary fiber is at least one selected from the group consisting of guanhua bean gum, pectin, and locust bean gum . Item 3 is the composition for hindering the absorption of dietary fat according to item 1, wherein the water-soluble dietary fiber is Guanhua bean gum. 200533300 The fourth member, as described in item 1, is used to hinder dietary fat. It is 1 part by weight with respect to (1) chitosan contained, and it is a product containing water-soluble dietary fiber, and the water-soluble Sexual food ratio: ι Chinese bean gum, pectin, jacaranda, and locust bean gum 10 15 The 5th member of the 1st item is used to prevent the fat from being eaten by fat. Parts by weight are based on ^ weight ^ product 'contains (2) water-soluble dietary fiber' and the water-soluble dietary fiber:;: the ratio of at least huahua gum, pectin, and locust bean gum is at least ^ in The composition for blocking the absorption of fat by the 6th item and the 3rd item is contained in 3 to 1 part by weight of the chitosan 3 (1) (2) Guanhua bean gum. Item 7 The composition according to any one of Items 1 to 6 for preventing the absorption of fat from eating, which is in a form suitable for oral administration. The eighth member is a composition for hindering the absorption of dietary fat according to any one of items 1 to 6, which has a form of food and drink, and the form of the food and drink is selected from the group consisting of snacks, drinks, and supplements (suppi_nt). Group 0) In addition, the present invention can provide the methods listed in items 9-17 below to hinder the absorption of dietary fat 20. Item 9-A method for inhibiting dietary fat absorption in a person who needs to block dietary fat absorption, is to make the human body orally ingest an effective amount of the composition of any one of items 1 to 8. Item 10-A method for making dietary fat excretion in a human body that requires dietary fat to be excreted 200533300 The method for causing the human body to orally ingest an effective amount of the composition of any one of items 1 to 8. Item 11 is an anti-obesity method for a human body in need of anti-obesity, which is a method in which the human body orally ingests an effective amount of the composition of any one of Items 1 to 8. 5 Item 12: A method for inhibiting an increase in serum triglyceride after diet in a human body with a large amount of fat intake, which is a method in which the human body orally ingests an effective amount of the composition of any one of Items 1-8 . Item 13: The use of the composition of any one of items 1 to 8 in which the composition is used to impede the absorption of dietary fat. 10 Item 14 A use of the composition according to any one of items 1 to 8 for use of the composition to excrete dietary fat from the body. Item 15 A use of the composition of any one of items 1 to 8 to use the composition for anti-obesity. Item 16 The use of a composition according to any one of Items 1-8, which is used to suppress an increase in serum triglyceride after diet. Item 17: The use of (1) chitosan and (2) water-soluble dietary fiber, which are used to produce the composition of any one of Items 1 to 8, wherein the water-soluble dietary fiber is At least one selected from the group consisting of guanhua bean gum, pectin, thorn cloud gum, and locust bean gum. 20 The composition of the present invention can achieve a very excellent fat absorption blocking effect. This fat absorption inhibiting effect is more excellent than when chitosan is used alone. That is, the present invention has been found to be completed by a combination of chitosan and the aforementioned specific water-soluble food fiber that exerts a synergistic effect on the effect of inhibiting fat absorption. 10 200533300 In the present invention, the water-soluble dietary fiber that can be used in combination with chitosan is selected from the group consisting of guanhua bean gum, pectin, jacaranda gum, and locust bean gum. Of these, (a) is preferably at least one selected from the group consisting of guanhua bean gum, pectin, and locust bean gum. A particularly suitable water-soluble dietary fiber for use with chitosan is (b) Guanhua bean gum. In the composition of the present invention, each component used as an active ingredient is known in the food field as a food material, a food additive, and the like, and it is easily available. For example, chitin obtained by applying crustacean crustaceans, such as crabs and shrimps, to acid treatment, that is, as much as N-acetamido_D_10 glucosamine and D-glucosamine combined Chitin polymerase can be obtained as a component (1) by subjecting the saccharides to alkali treatment. The chitosan is also a non-bathable dietary fiber containing polyglucosamine as a component, which can be prepared according to a predetermined method. If you want to make it easier, you can get it by business methods. The content of the aforementioned (1) component in the composition of the present invention is not particularly limited as long as it can reach the cost of the fruit of the invention. Usually, the composition contains 0.1% by weight or more, and preferably contains 2 to 80% by weight, and more preferably contains 2 to 50% by weight. In the present invention, 'the material sentence τ constituting the (2) component which is used in combination with the aforementioned (1) component belongs to the water / cereal dietary fiber (20SDF)' in general 'in the food field It is used as a food and beverage additive (thickening stabilizer). The ° Kuanhua bean gum of sheep's mouth is made from the seeds of Guanhua bean tree of the leguminous family, which is still extracted from the germ. It is produced mainly from polysaccharides combining glucose and mannose. Ingredients (about 78 ~ 82% galacid 11 200533300 mannan). The Guanhua bean gum of the present invention also includes Guanhua obtained by decomposing and processing the Guanhua bean gum with enzymes (such as hemicellulase, galactomaimanase, etc.). Degradation of glutinase. Pectin is a kind of polysaccharides that form the skeleton of plant tissues. 5 It can be prepared from various plants. It consists essentially of a conjugate of galactouronicacid which has undergone amidation. Pectin can be broadly divided into water-soluble pectin ester acids; insoluble protopectin that combines with other polysaccharides, proteins, and inorganic substances; and pectin acid that can decompose the original pectin. The invention can use any of these. The degree of methyl esterification of methylated galacturonic acid constituting pectin 10 is known to be about 0 to 80%, and any degree of fluorenyl esterification may be used in the present invention. Citrus aurantium gum is a seed polysaccharide prepared from the germ of a seed of the kiwi family, Acanthaceae, α cd / osa Z ·). Locust bean gum is a polysaccharide (containing about 88% galactomannan) prepared from the germ extract 15 of the seeds of Robinia pseudoacacia (⑽). These substances can be prepared according to the law from various plants containing them as described above, and can be obtained by commercial methods for simplicity. (2) of these: One kind may be used alone or two or more kinds may be combined, and then used in combination with the chitosan of the aforementioned (丨) component. 2 0 | The amount of the aforementioned component (2) contained in the composition for hindering the absorption of dietary fat of the present invention is not particularly limited before it reaches the effect of the invention. Generally, its blending amount is 1 part by weight with respect to the aforementioned (1) knife included in the composition of the present invention, and the total amount of Guanhua bean gum, pectin, thorn cloud gum, and locust bean gum is in the range of parts by weight of Mo. And, it is preferably in the range of 3-7 parts by weight, and more preferably in an amount of about 5 12 200533300 parts by weight. By using the above-mentioned (1) component in combination with the above-mentioned (2) component, especially in the above-mentioned specific mixing ratio, the (1) component and the (2) component in the obtained composition will multiply each other , And can exert an excellent effect of preventing fat absorption. In addition, in the composition of the present invention, the (1) component and (2) component, which are effective ingredients, have been used in Japan as food and food additives, and safety has also been confirmed as a material that can be used continuously. Therefore, the composition of the present invention for preventing the absorption of dietary fat, which is a combination of these combinations, is orally ingested (administered) is harmless and can be used continuously. The focus of the composition for hindering the absorption of dietary fat of the present invention is to contain the aforementioned (1) ingredient and (2) ingredient as essential ingredients, but it is not necessary to consist of only these ingredients, without impairing the original diet of the composition of the present invention Under the premise of obstructing fat absorption and other effects, in order to prepare the composition into a form that can be easily ingested or administered, it can contain edible ingredients that are acceptable for food hygiene or ingredients that are acceptable for formulation. Comes as an auxiliary ingredient. In addition to the aforementioned components (1) and (2), in the composition of the present invention, the food is hygienically acceptable edible ingredients that can be included as supplementary ingredients as needed, in addition to the three major nutrients such as sugars, fats and proteins. In addition, it also contains 20 food ingredients and food additives that are generally known for use in preparing food and beverage. More specifically, the food materials and food additives include: sweeteners such as natural sweeteners (other than sugars) and synthetic sweeteners; vitamins and minerals (electrolytes and trace elements); natural flavors and synthetic flavors Other flavoring agents; coloring agents; preservatives; natural fruit juices, natural pulp, etc. 13 200533300 In addition, the sword-making acceptable ingredients of the aforementioned auxiliary ingredients include preparations known to be used in the preparation of medicaments for administration, such as occupational agents (fillers), 1 agent, Binding agent, moisturizing agent, disintegrating agent, smoothing agent, extender and surfactant. The preparation can be prepared according to the desired dosage unit form and 5 is appropriately selected from these. The composition of the present invention can be prepared into an oral composition in accordance with a predetermined method by using the aforementioned component (1), the peptone component, and as needed, and assisting in forming a knife. Oral-grade products Daggera Oral medicines, medicines, and food and beverages. In addition, it is preferable that the diet 10 15 20 Mouth Mouth Mouth Mouth include functional foods and foods for specific health care which have an effect of hindering the absorption of dietary fat. The composition of this Maoming that prevents the absorption of dietary fat can take the form of a drug or a quasi-drug as long as it can be used orally, and is subject to special restrictions. This form includes, for example, pills, powders, suspensions, emulsions, granules, capsules, gums, syrups and the like. The modulation method for preparing these forms can be performed according to the general medical method. "X shellfish, please take your mouth" "==: Drinks that have a composition that interferes with the absorption of dietary fat = sad and not continent _ system, such as: (A) milk drink sleepy drinks, refreshing drinks, carbolic acid drinks, fruit juice drinks , Vegetable drinks, vegetable and fruit juice drinks, green drinks, alcoholic beverages, brown drinks, black tea drinks, green tea, mixed tea, fancheng materials, beverage forms such as beverages, Gaya, etc. ) Puddings, puddings, fruit puddings, puddings, fruit lings, milk shreds, yogurt, etc .; (C) ice cream, milk ice, Lact0-ice, Hungarian ice, popsicles, etc .; soft Sugar (including 14 200533300 containing milk candy, nougat, QQ sugar, marshmallow, etc.) and hard fruit (including toffee, etc.) and other confectionery; (E) hard biscuit, cookies , Crackers, persimmon mochi, pancakes, coriander sticks, burdock sticks, and other snacks, as well as puff pastry products using an extruder, etc. (F) Bread, vegetable bread Bread form; (G) cormorant form, etc .; (H) soup, juice, etc. State; stuffed products such as bonito board, sausage, etc .; (J) food form of conditioning package such as curry;面, spaghetti and macaroni noodles; other supplements (complementary foods) in the form of pills, tablets, 10 tablets, granules, powders, freezers, capsules, etc .; (M) pure fluid food, high Nutrient-rich liquid foods such as oral liquid foods, etc. Among them, the preferred food and drink products include (A) beverage forms, (E) snack forms, and (L) supplements. The composition for hindering the absorption of 15 fats of dietary fat of the present invention is not only suitable to mix the components (1) and (2) in the aforementioned proportions, but also can be used conventionally in preparation according to the form of the desired food and drink and the manufacturing method thereof. In addition, when the composition for hindering the absorption of dietary fat of the present invention is prepared into a liquid form such as a beverage form, although it is not particularly limited, it should preferably be adjusted to a viscosity of 1 to 3000 mpa · s (compared to 20). Preferably 10 ~ 100mpa · s, And more preferably within the range of 50 ~ 500mPa · s) (Conditions for measuring viscosity: use

Brookfield型黏度計,30轉/分,2〇± 〇.5。〇。 本發明之用以阻礙膳食脂肪吸收之組成物之投予量可 依該組成物之形態(飲食品形態或醫藥品形態)、欲投予之患 15 200533300 者又予目@ (所需效果之程度)等而適當決定,並無特別限 制曰叙而g,可以1曰成人1人攝取前述(1)成分0.1〜5g程 度之量為標準,如此可得充分之效果。 本發明之用以阻礙膳食脂肪吸收之組成物可透過其攝 ;舌體内阻礙膳食脂肪之吸收,而無需透過限制飲食 及投藥即可防止肥胖,並防止循環系統疾病、呼吸系統疾 病、糖尿病等各種合併症之發病。 因此,本發明可提供一種於需要阻礙膳食脂肪吸收之 人翻阻礙膳食脂肪吸收之方法,係使該人體經口攝取有 10 效量之本發明組成物者。 此外,本發明可提供一種於需要腾食脂肪排出體外之 人體中使勝食脂肪排出體外之方法,係使該人體經口攝取 有效量之本發明組成物者。 15 20 再者,本發明亦提供一種對需要抗肥胖之人體之抗肥 胖方法,係使該人體細攝取有效量之本發明組成物者。 另外,本發明亦可提供_種於脂肪攝取量較多之人體 中抑制飲健血清三酸甘油脂上权方法,其錢該人體 經口攝取有效量之本發明組成物者。 本發明之前述方法中,本發明組成物對於需 人體的投㈣射轉*、進切轉彳 1 予時期與用餐時間(脂肪之攝 而將# 到本發明組《可❹以鄕诗性,但若考慮 I &月日肪吸收之作用, 予時期宜與用餐同時或在用餐前後 蛛、又 即,宜於人體進行膳食脂肪吸收切刀鐘之關内。意 f期中,口服攝取本發 16 200533300 明組成物而可對人體發揮作用。 此外,本發明亦可提供下述用途,即··使本發明組成 物用以阻礙膳食脂肪吸收之用途;使本發明組成物用以使 膳食脂肪排出體外之用途;使本發明組成物用以抗肥胖之 5用途;使本發明組成物用以抑制飲食後之血清三酸甘油脂 上升之用途。 此外,本發明亦提供一種(1)幾丁聚醣及(2)水溶性食物 纖維之用途,係使該等用以製造第卜8項中任一項之組成物 者,其中該水溶性食物纖維係選自由關華豆膠 '果膠、刺 雲實膠及刺槐豆膠所構成之群組中之至少丨種。Brookfield viscometer, 30 rpm, 20 ± 0.5. 〇. The dosage of the composition for hindering the absorption of dietary fat according to the present invention may depend on the form of the composition (dietary product form or pharmaceutical form), and the patient who wants to administer it. The degree is determined as appropriate, and there is no particular limitation on the amount of g, and the amount of the ingredient (1) in the range of 0.1 to 5 g can be used as a standard for one adult and one person, so that a sufficient effect can be obtained. The composition for blocking the absorption of dietary fat of the present invention can be taken through it; the absorption of dietary fat in the tongue can be prevented, and obesity can be prevented without restricting diet and medication, and circulatory diseases, respiratory diseases, diabetes, etc. The onset of various comorbidities. Therefore, the present invention can provide a method for obstructing the absorption of dietary fat in a person who needs to block the absorption of dietary fat, which is to make the human body orally ingest 10 effective amounts of the composition of the present invention. In addition, the present invention can provide a method for excretion of dietary fat in a human body which needs to eat fat and excrete the body, which is to enable the human body to orally ingest an effective amount of the composition of the present invention. 15 20 Furthermore, the present invention also provides an anti-obesity method for a human body in need of anti-obesity, which enables the human body to finely ingest an effective amount of the composition of the present invention. In addition, the present invention can also provide a method for inhibiting the right to drink serum triglyceride in a human body with a large amount of fat intake, which can effectively ingest an effective amount of the composition of the present invention by the human body. In the aforementioned method of the present invention, the composition of the present invention requires a human body to shoot, turn into, and cut into a given period of time and meal time (photographed by the fat # to the group of the present invention, "can be used as a poem, However, if the effect of I & moon fat absorption is considered, it is advisable to administer the dietary fat absorption knife at the same time as the meal or before or after the meal. 16 200533300 The composition of the present invention can exert effects on the human body. In addition, the present invention can also provide the following uses, that is, the use of the composition of the present invention to prevent the absorption of dietary fat; the composition of the present invention is used to make the dietary fat Use for excretion; use of the composition of the present invention for anti-obesity; use of the composition of the present invention for inhibiting the rise of serum triglyceride after diet. In addition, the present invention also provides (1) chitin The use of polysaccharides and (2) water-soluble dietary fiber are those used to manufacture the composition of any one of item 8, wherein the water-soluble dietary fiber is selected from the group consisting of Guanhua bean gum, pectin, Thorn cloud glue and thorn Shu at least the species of the group consisting of bean gum.

特別是,若依利用本發明組成物之阻礙膳食脂肪吸收 之方法,則可抑制餐後之血清三酸甘油脂上升。血清三酸 甘油脂係於餐後上升,尤其是隨著膳食脂肪攝取量之增 加,其上升傾向亦隨之增加。此種用餐後之血清三酸甘油 月旨上升於異常提高之狀態或此上升狀態延長之狀態即稱為 餐後高血脂症(Postprandial hyperlipidemia)(多田紀夫著,動 遞^’ 27(12),319-325 (2000))。近年已有報告指出,Z 種餐後咼血脂症為冠狀動脈疾病之獨立危險因子(參照··多 田紀夫著,鱼麗^、27(12),319-325 (2000): Patsch,JR.,et al” Areterioscler. Thromb·,12, 1336-1345 (1992)等)。 若依利用本發明組成物之阻礙膳食脂肪吸收之方法, 可顯著抑制(阻礙)來自飲食之脂肪吸收。這也意味著可抑制 4後之血清三酸甘油脂上升。因此,本發明組成物可透過 其攝取而減低餐後高血脂症之發病風險及綠動脈疾病之 17 200533300 發病風險。如前述般,本發明亦可提供一種餐後高血脂症 之治療方法及冠狀動脈疾病之預防方法。 此外,本發明尚包含下述樣態。 a· —種增強幾丁聚醣之阻礙膳食脂肪吸收作用之方 法’其特徵在於:將(丨)幾丁聚醣與(2)選自於由關華豆膠、 果膠、刺雲實膠及刺槐豆膠之至少丨種成分組合使用。 b· —種使幾丁聚醣與關華豆膠、果膠、刺雲實膠或刺In particular, according to the method of using the composition of the present invention to inhibit the absorption of dietary fat, it is possible to suppress an increase in serum triglyceride after a meal. Serum triglycerides rise after meals, especially as dietary fat intake increases, so does the tendency to rise. The post-meal serum triglyceride rises to an abnormally elevated state or a state in which this elevated state is prolonged is called Postprandial hyperlipidemia (by Tadano Kifu, Mobil ^ '27 (12), 319-325 (2000)). In recent years, it has been reported that Z kinds of postprandial dyslipidemia are independent risk factors for coronary artery disease (refer to: Tada Yufu, Yuri ^, 27 (12), 319-325 (2000): Patsch, JR., et al "Areterioscler. Thromb., 12, 1336-1345 (1992), etc.) According to the method of using the composition of the present invention to inhibit the absorption of dietary fat, it is possible to significantly inhibit (block) the fat absorption from the diet. This also means Can inhibit the rise of serum triglyceride after 4. Therefore, the composition of the present invention can reduce the risk of postprandial hyperlipidemia and the risk of green artery disease by 2005. As mentioned above, the present invention can also Provided is a method for treating postprandial hyperlipidemia and a method for preventing coronary artery disease. In addition, the present invention also includes the following aspects. A · A method for enhancing the effect of inhibiting dietary fat absorption by chitosan, which is characterized by : Use (丨) chitosan and (2) at least one of the components selected from the group consisting of Guanhua bean gum, pectin, ganoderma gum, and locust bean gum. B. — Chitin With Guanhua bean gum, pectin, Thorn cloud glue or thorn

槐豆膠之阻礙膳食脂肪吸收作用相互增強的方法,其特徵 在於·將(1)幾丁聚醣與(2)選自於由關華豆膠、果膠、刺雲 10實膠及刺槐豆膠之至少1種成分組合使用。 c·如前述a·之增強幾丁聚醣之阻礙膳食脂肪吸收作用 之方法,其係將相對於⑴幾丁聚重量份總量為W0重量 伤比例之(2)選自於由關華豆膠、果膠、刺雲實膠及刺槐豆 膠之至少1種成分組合使用。 15 d.如前述b•之使幾丁聚醣與關華豆膠、果膠、刺雲實 :或刺槐轉之阻祕食㈣《翻相互職的方法, '、係將相對於⑴幾丁聚醣1重量份總量為重量份比例 之(2)選自於由關華豆膠、杲 们種成分組合如。祕、刺雲實膠及刺槐豆膠之至 20 強方法,其係使膳食脂肪吸收阻礙作 法0 e·如前述1至d·中之任一膳 食月旨肪吸收阻礙作用之增 用成相乘性增強的方 發明之效果 於由關華豆 本發明組成物係將⑴幾丁聚聰及(2)選自 18 200533300 膠、果膠、刺雲實膠及刺槐豆膠之至少1種成分組合,藉此 使(1)成分之阻礙膳食脂肪吸收之作用顯著增強,結果可發 揮非常優異之阻礙膳食脂肪吸收之作用。因此,本發明組 成物可製為膳食脂肪吸收阻礙劑及抗肥胖劑等,在醫療領 域上甚為有用,此外,於食品領域中則可製為一種飲食品, 其具有使透過飲食而攝取之脂肪不致被體内吸收而有效排 出體外的功能,故而甚為有用,特別是製成機能性食品(特 定保健用食品)。 囷式簡單說明 10 第1圖係一顯示實驗例3之試驗結果之曲線圖(橫軸:給 _後時間(小時)、縱軸:血漿三酸甘油脂濃度(mg/dL))。 第2圖係一顯示實驗例4之試驗結果之長條圖(縱軸:肝 臟三酸甘油脂量(mg/g肝臟)。 第3圖係一曲線圖,顯示依實驗例5所示試驗所求出血 15 清三酸甘油脂濃度之結果(橫軸:脂肪食攝取後時間(時 間)、縱軸:血清三酸甘油脂濃度(mg/dL))。 【實施方式 本發明之最佳實施形態 列舉實驗例及實施例如下以說明本發明,但本發明並 20不受該等實驗例等限制。此外,於以下之實驗例等中,只 要無特別指明,則配合比例之「%」為重量%,「份」為重 量份。 f驗例1 為評估本發明組成物之阻礙膳食脂肪吸收作用而進行 19 200533300 下述貝驗此實驗係使用大鼠作為被驗動物,調查該被驗 大既攝取、、且a有⑴幾丁聚_與⑺關華豆膠或果膠之飼料 後對於糞中脂肪排泄量的影響。 1.被驗動物及飼育修f 5 被驗動物係使用雄性SD大鼠(6週齡、體重: 192〜2〇8g)(購人來源:CL⑷apanjne )32_· 4隻)。該 等被驗動物H驗期間係個別收容於22Wx 29Wx 21H 之不鏽鋼製籠中,以溫度22〜24〇c、濕度51〜6〇%及照明U 小時(7時-I9時)/日之條件下進行飼育。飼料至實驗開始(開 10始投予混合餌)為止係給予下記組成之大鼠標準飼料 (AIN93G配合飼料,粉末狀,〇riemal心抓c〇,ud ),水則 係自由攝取自來水。A method for mutual enhancement of the effect of locust bean gum on inhibiting the absorption of dietary fat, characterized in that (1) chitosan and (2) are selected from the group consisting of Guanhua bean gum, pectin, ganoderma 10 and gum locust bean At least one of the ingredients of the gum is used in combination. c. The method for enhancing the effect of inhibiting dietary fat absorption of chitosan as described in a. above, which is selected from Guanhuadou (2) based on the total weight percentage of WO with respect to the total weight of chitin. A combination of at least one component of gum, pectin, muscari, and locust bean gum is used in combination. 15 d. As described in b. Above, Chitosan and Guanhua bean gum, pectin, thorn cloud fruit: or Robinia pseudoacacia to prevent the secret food ㈣ "the method of transmutation, ', will be relative to ⑴Chitin The total amount of 1 part by weight of glycan is (2) selected from the group consisting of guanhua bean gum and glutamate. The top 20 methods of Secret, Sophora acuminata and Locust Bean Gum, which are used to make dietary fat absorption obstructive. 0 e · As in any one of the foregoing 1 to d ·, the multiplication of the obstruction of fat absorption is multiplied. The effect of the formula with enhanced sexual properties is to combine at least one ingredient selected from the group consisting of 18 200533300 gum, pectin, cuspidaceae, and locust bean gum by the composition of the present invention of Guan Huadou. This significantly enhances the effect of the component (1) that hinders the absorption of dietary fat, and as a result, it can exert a very excellent effect that hinders the absorption of dietary fat. Therefore, the composition of the present invention can be prepared as a dietary fat absorption inhibiting agent, an anti-obesity agent, etc., and is particularly useful in the medical field. In addition, in the food field, it can be prepared as a food and drink product, which has the ability The function of fat is not absorbed by the body and is effectively excreted from the body, so it is very useful, especially as a functional food (specific health food). Simple explanation of formula 10 Figure 1 is a graph showing the test results of Experimental Example 3 (horizontal axis: time after giving (hours), vertical axis: plasma triglyceride concentration (mg / dL)). Figure 2 is a bar graph showing the test results of Experimental Example 4 (vertical axis: liver triglyceride amount (mg / g liver). Figure 3 is a graph showing the laboratory according to Experimental Example 5 Result of bleeding 15 triglyceride concentration (horizontal axis: time (time) after ingestion of fatty food, vertical axis: serum triglyceride concentration (mg / dL)). [Embodiment The best embodiment of the present invention Experimental examples and examples are listed below to explain the present invention, but the present invention is not limited by these experimental examples, etc. In addition, in the following experimental examples and the like, unless otherwise specified, the "%" of the blending ratio is weight %, “Parts” are parts by weight. F Test Example 1 In order to evaluate the effect of the composition of the present invention on obstructing the absorption of dietary fat, 19 200533300 The following test was performed using rats as test animals. Effects of ingestion of a chitin poly _ and feeds of Tongguanhua bean gum or pectin on fat excretion in feces. 1. Test animals and breeding f 5 Test animals used male SD Rat (6 weeks old, weight: 192 ~ 208g) (purchased from: CL⑷apanjne) 32_ · 4 only). These animals were individually housed in stainless steel cages of 22Wx 29Wx 21H during the H-test period. The temperature was 22 ~ 24 ° c, the humidity was 51 ~ 60%, and the lighting was U hours (7-9pm) / day. Breeding. Feed until the beginning of the experiment (mixed bait was started at 10) was given standard rat feed (AIN93G compound feed, powder, 〇riemal heart c0, ud), and water was freely taken from tap water.

15 20 <大鼠標準飼料組成(單位:g)> 酪蛋白 200 α-玉米澱粉 132 β-玉米澱粉 397.5 蔬糖 102.5 大豆油 70 混合礦物質之ΑΙΝ93 35 混合維生素之ΑΙΝ93 10 L-半脱胺酸 3 丁基經基酉昆 0.014 纖維素 50 合計 1000.014 20 200533300 此外’混合礦物質之AIN93及混合維生素之AIN93均使 用 〇HemalYeastc〇.,亂製者。15 20 < Rat standard feed composition (unit: g) > Casein 200 α-Corn Starch 132 β-Corn Starch 397.5 Vegetable Sugar 102.5 Soybean Oil 70 ΑΙΝ93 with mixed minerals 35 ΑΙΝ93 with mixed vitamins 10 L-half Glutamate 3 butyl hydrochloride 0.014 Cellulose 50 Total 1000.014 20 200533300 In addition, AIN93 with mixed minerals and AIN93 with mixed vitamins both use 〇HemalYeastc〇.

將各群大鼠之飼料 替換為下述各混餌飼料並開始實 5驗。以各混_飼料飼育6天。此外,對照群大鼠則繼續給予 標準飼料。 實,驗群1 :幾丁聚醣1%+關華豆膠5%混餌飼料:將標準 飼料之玉米澱粉3 9 7 · 5 g改為3 3 7 .5g,並添加幾丁聚醣l〇g及 關華豆膠50g之飼料 1〇 實驗群2 :幾丁聚醣1%+果膠5%混餌飼料:將標準飼料 之玉米丨殿粉397.5g改為337.5g,並添加幾丁聚醣l〇g及果膠 50g之飼料。 比較群1 :幾丁聚醣1%混餌飼料:將標準飼料之玉米 殿粉397.5g改為387.5g,並添加幾丁聚醣10g之飼料。 15 比較群2 :關華豆膠5%混餌飼料:將標準飼料之玉米 澱粉397.5g改為347.5g,並添加關華豆膠50g之飼料。 比較群3 ··果膠5%混餌飼料:將標準飼料之玉米澱粉 397.5g改為347.5g,並添加果膠50g之飼料。 此外,幾丁聚醣係使用甲陽化學株式會社製(Koyo 20 Chemical Company Limited,Lot No.0817-13 ’ 黏度: 105mPa · s,脫乙醯化度:89.1%)者。關華豆膠係使用三榮 源FF1株式會社(San-Ei Gen F.F.I.,Inc·)製「比斯托普 (BIS-TOP) TM」。果膠則使用三榮源FFI株式會社(San-Ei Gen F.F.I.,Inc.)製果膠「SM666」(商品名)。 21 200533300 3.測定頊目及測定方法 自實驗開始至第4〜6日,將濾紙舖在各群大鼠之飼育籠 下,並回收排出至其上之所有糞便。糞之回收係每日丨次, 於每日9:00-10:00之間進行。測定糞之濕重量後,進行凍結 5乾燥(5日)。將經攪拌器均勻粉碎之乾燥糞便製為測定糞便 中脂肪含量用之樣本。糞便中之脂肪含量係以F〇lch之方法 (J. Biol. Chem·,226, 499(1957))測定。總脂肪排泄量係以如 下式1算出。外觀脂肪吸收率則以如下式2算出。 式1 :總脂肪排泄量=A X B 1〇 A :糞便中脂肪含量 B:乾燥糞便濕重量 式2·外觀脂肪吸收率(x^ioo^c/Dx 1〇〇] C ·· 1日之糞便中總脂肪排泄量 D: 1日之平均脂肪攝取量(平均攝餌量X 7%)< 1/1〇〇) 15 所得結果係以平均值± 95%信賴區間值表示。相乘性 之檢定則以使用統計解析軟體8八8 Versi〇n 8 (SAS Institute 製)之 1-Way AN〇VA(ADDITIVE EFFECT)進行。 4 ·測定結果 茲將結果示於下述表1。 22 200533300 表1 群 總脂肪排泄量(mg/3曰) 外觀上之脂肪吸收率(%、 實驗群1 3236+ 691* 19.1± 8.7* 實驗群2 2085+ 750# 51.0+ 14.8# 比較群1 428+ 533 91.6+ 9.3 * 比較群2 598+ 180 84.7+ 5.2 ·— 比較群3 637+ 70 84.6± 0.8 ' 對照群 140+ 38 97.0± 0.8 由表1所示結果可確知下述事項。與對照群相較下,比 較群1、比較群2及比較群3之總脂肪排泄量增加。相對於 此,併用幾丁聚醣與關華豆膠之實驗群1及併用幾丁聚醣與 5果膠之實驗群2的總脂肪排泄量與單獨使用幾丁聚醣(比較 群1)、關華豆膠(比較群2)及果膠(比較群3)時相較下顯著增 加。此一效果透過統計解析,顯示為相乘增加效果(表中, 以標記★號及#號表示之)。此外,就外觀上之脂肪吸收率 而言,實驗群1及實驗群2與單獨使用幾丁聚醣 Π)關華豆膠(比較群2)及果膠(比較群3)時相較下亦頻著降 低。此-效果透過統計解析,顯示為相乘降低效果(表中, 以標記★號及#號表示之)。 實驗例2 15 本發明組成物之阻礙膳食脂肪吸收作用,而進 行如下實驗。該實驗係使用與實驗例^同週齡 被驗動物,再«鱗概域攝取組 ⑺刺槐豆敎_料„概 ==與 造成之影響。 ^異1^日肪排泄量所The feed of each group of rats was replaced with each of the following mixed bait feeds and the test was started. They were fed with mixed feed for 6 days. In addition, rats in the control group continued to receive standard diets. Test group 1: Chitosan 1% + Guanhua bean gum 5% mixed bait feed: change corn starch 3 9 7 · 5 g of standard feed to 3 3 7 .5 g, and add chitosan l〇 g and Guanhua bean gum 50g feed 10 Experimental group 2: Chitosan 1% + pectin 5% mixed bait feed: Change the standard feed corn 丨 dian powder 397.5g to 337.5g, and add chitosan 10 g and 50 g of pectin feed. Comparative group 1: Chitosan 1% mixed bait feed: 397.5g of corn diet powder of standard feed was changed to 387.5g, and 10g of chitosan was added to the feed. 15 Comparative group 2: Guanhua bean gum 5% mixed bait feed: 397.5g of corn starch of standard feed was changed to 347.5g, and 50g of Guanhua bean gum was added. Comparative group 3 · · Pectin 5% mixed bait feed: 397.5 g of corn starch as standard feed was changed to 347.5 g, and 50 g of pectin was added as feed. In addition, as the chitosan, a product made by Koyo Chemical Co., Ltd. (Koyo 20 Chemical Company Limited, Lot No. 0817-13 'viscosity: 105 mPa · s, deacetylation degree: 89.1%) was used. Guanhua bean gum uses "BIS-TOP TM" manufactured by San-Ei Gen F.F.I., Inc. As the pectin, "SM666" (trade name) manufactured by San-Ei Gen F.F.I., Inc. was used. 21 200533300 3. Measurements and measurement methods From the beginning of the experiment to the 4th to 6th days, filter paper was spread under the rearing cages of each group of rats, and all the feces discharged thereon were recovered. Feces are recovered 丨 times daily, between 9: 00-10: 00 daily. After measuring the wet weight of feces, it was freeze-dried (5 days). The dried feces uniformly pulverized by a stirrer were prepared as samples for measuring the fat content in the feces. Fat content in feces was measured by the method of Folch (J. Biol. Chem., 226, 499 (1957)). Total fat excretion is calculated by the following formula 1. The external fat absorption rate was calculated by the following formula 2. Formula 1: Total fat excretion amount = AXB 1〇A: Fat content in feces B: Wet weight of dry feces Formula 2 · Appearance fat absorption rate (x ^ ioo ^ c / Dx 100) C ·· 1 day of feces Total fat excretion D: The average fat intake on the 1st day (average food intake X 7%) < 1 / 1〇) 15 The results obtained are expressed as the mean ± 95% confidence interval value. The multiplicative test is performed using 1-Way ANOVA (ADDITIVE EFFECT) of statistical analysis software 88.8 Versión 8 (manufactured by SAS Institute). 4 • Measurement results The results are shown in Table 1 below. 22 200533300 Table 1 Total fat excretion in group (mg / 3) Apparent fat absorption rate (%, experimental group 1 3236+ 691 * 19.1 ± 8.7 * experimental group 2 2085+ 750 # 51.0+ 14.8 # comparative group 1 428 + 533 91.6+ 9.3 * Comparative group 2 598+ 180 84.7+ 5.2 · —Comparative group 3 637+ 70 84.6 ± 0.8 'Control group 140+ 38 97.0 ± 0.8 From the results shown in Table 1, the following can be confirmed. Compared with the control group In comparison, the total fat excretion of comparative group 1, comparative group 2, and comparative group 3 increased. In contrast, experimental group 1 using chitosan and Guanhua bean gum and using chitosan and 5 pectin The total fat excretion of experimental group 2 increased significantly compared with that when chitosan (comparative group 1), Guanhua bean gum (comparative group 2), and pectin (comparative group 3) were used alone. This effect is seen through Statistical analysis shows the effect of multiplication (in the table, marked with ★ and #). In addition, in terms of appearance fat absorption rate, experimental group 1 and experimental group 2 used chitosan alone Π) Guanhua bean gum (comparative group 2) and pectin (comparative group 3) also decreased frequently compared with the lower ones. This-effect is displayed as a multiplying reduction effect through statistical analysis (in the table, it is marked with ★ and #). Experimental Example 2 15 The composition of the present invention inhibited the absorption of dietary fat, and the following experiments were performed. This experiment uses experimental animals of the same age as the experimental example, and then «Squamble Field Ingestion Group ⑺ Locust Bean Bean _Materials« Summary == and the effects caused by ^ 异 1 ^ day fat excretion

23 200533300 被驗動物係使用雄性SD大鼠(8週齡,體重: 312〜365g)(講入來綠:CLEA JaPan,Inc.)24隻(6群X 4隻)。該 等被驗動物於試,㈤係侧收容於2衝 29Wx 21H(cm) 之不鐘鋼製複中,以溫度22〜24°C、濕度51〜60%及照明12 小曰之條件下進行飼育。飼料至實驗開始(開 始投予混合餌)為止係給予下記組成之大氣標準飼料 (AIN93G配合飼料,粉末狀,〇rientd价抓c〇·,趾),水則 自由攝取自來水。 2.實驗方法及實驗$ 將各群大鼠之飼料替換為下述各混餌飼料並開始實 驗。以各混餌飼料飼育6天。此外,對照群大鼠則繼續給予 標準飼料。 實驗群3 ··幾丁聚醣1°/。+刺槐豆膠5%混餌飼料:將標準 飼料之玉米澱粉397.5g改為337.5g,並添加幾丁聚醣1〇g及 15 刺槐豆膠50g之飼料。23 200533300 Animals tested were male SD rats (8 weeks old, weight: 312 ~ 365g) (speaking green: CLEA JaPan, Inc.) 24 (6 groups X 4). These test animals were tested, and the sacral system was housed in a 2-ch 29Wx 21H (cm) stainless steel compound, and the temperature was 22 ~ 24 ° C, humidity was 51 ~ 60%, and lighting was performed for 12 hours. Feeding. Feed until the beginning of the experiment (beginning of the mixed bait) was given an atmospheric standard feed (AIN93G compound feed, powder, 〇rientd valence c0 ·, toe) with the following composition, and water was free to take tap water. 2. Experimental method and experiment $ Replace the feed of each group of rats with the following mixed bait feeds and start the experiment. Each mixed bait was fed for 6 days. In addition, rats in the control group continued to receive standard diets. Experimental group 3 · Chitosan 1 ° /. + Locust bean gum 5% mixed bait feed: 397.5g of corn starch for standard feed was changed to 337.5g, and 10g of chitosan and 50g of locust bean gum were added.

比較群4 :幾丁聚醣1%混餌飼料:將標準飼料之玉米 澱粉397.5g改為387.5g,並添加幾丁聚醣10g之飼料。 比較群5 :刺槐豆膠5%混餌飼料:將標準飼料之 殿粉397.5g改為347.5g,更添加刺槐丑膠50g之飼料。 20 此外,幾丁聚醣係使用甲陽化學株式會钍Comparative group 4: Chitosan 1% mixed bait feed: 397.5g of corn starch of standard feed was changed to 387.5g, and 10g of chitosan was added to the feed. Comparative group 5: locust bean gum 5% mixed bait feed: 397.5 g of standard meal powder was changed to 347.5 g, and 50 g of locust ugly gum was added. 20 In addition, the chitosan line uses Jiayang Chemical Co., Ltd.

Chemical Company Limited,Lot No.0817-13,零占 l〇5mPa · s,脫乙醯化度:89.1%)者。刺槐豆膠則隹^ °y〇 度 源 株式會社(San-Ei Gen F.F.I.,Inc.)製「比 淅托 (BIS-TOP) ™D-30」。 榮普 24 200533300 3. 測定項目及測定太沬 與實驗例1相同,於實驗開始4〜6日回收3天份之糞便全 量並測定重量,此外,測定回收之糞便中之脂肪含量。並 與實驗例1相同地算出總脂肪排泄量及外觀脂肪吸收率。 5 所得結果係以平均值± 95%信賴區間值表示。相乘性 之檢定係以使用統計解析軟體SAS Version 8 (SAS Institute 製)之 1-Way AN〇VA(ADDmVE EFFECT)法進行。 4. 測定結果 茲將結果示於下述表2。 10 表2 群 總脂肪排泄量(mg/3日) 外觀上之脂肪吸收率(%) 實驗群3 1〇84±斗斗了※ 78.3± 6炉 比較群4 274+ 74 94.9± 1.1 比較群5 516+ 227 89.5± 3.7 對照群 237+ 23 96.0+ 0.4 由表2所示結果可確知如下事項。與對照群相較下,即 使在單獨使用幾丁聚醣(比較群4)及刺槐豆膠(比較群5) 時,亦可見總脂肪排泄量之增加。與該等狀況(比較群4及 15 5)作對比,對幾丁聚醣併用刺槐豆膠之實驗群3則可見更顯 著之總脂肪排泄量增加。此實驗群3可見之效果於統計解析 上表示相乘增加效果(表中,標記※號表示之)。此外,外觀 上之脂肪吸收率與實驗群3中單獨使用幾丁聚醣(比較群句 及刺槐豆膠(比較群5)時相較,則顯著降低。此一效果透過 20統計解析,顯示為相乘降低效果(表中,標記※號表示之)。 由上述事實可知,若依本發明之(1)成分與(2)成分之組 25 200533300 合,可達成顯著之膳食脂肪吸收 1人丨且礙效果,其中,尤以幾 丁聚醣與關華豆膠之組合(實驗 二Chemical Company Limited, Lot No. 0817-13, zero occupancy 105 mPa · s, degree of deacetylation: 89.1%). Locust bean gum is 隹 ^ ° y〇 degrees "BIS-TOP ™ D-30" manufactured by San-Ei Gen F.F.I., Inc. Rongpu 24 200533300 3. Measurement items and determination of tadpoles The same as in Experimental Example 1, the whole amount of feces was recovered for 3 days and the weight was measured on the 4th to 6th days of the experiment, and the content of fat in the recovered feces was measured. The total fat excretion amount and apparent fat absorption rate were calculated in the same manner as in Experimental Example 1. 5 Results are expressed as mean ± 95% confidence interval values. The multiplicative test is performed by the 1-Way ANOVA (ADDmVE EFFECT) method using statistical analysis software SAS Version 8 (manufactured by SAS Institute). 4. Measurement results The results are shown in Table 2 below. 10 Table 2 Group total fat excretion (mg / 3 days) Apparent fat absorption rate (%) Test group 3 1 084 ± bucketed * 78.3 ± 6 furnace comparison group 4 274 + 74 94.9 ± 1.1 comparison group 5 516+ 227 89.5 ± 3.7 Control group 237+ 23 96.0+ 0.4 From the results shown in Table 2, the following matters can be confirmed. Compared with the control group, even when chitosan (comparative group 4) and locust bean gum (comparative group 5) were used alone, the total fat excretion increased. Compared with these conditions (Comparative groups 4 and 15 5), the experimental group 3 using locust bean gum combined with locust bean gum showed a more significant increase in total fat excretion. The effect seen in this experimental group 3 is a statistical multiplication increase effect (in the table, marked with a *). In addition, the appearance of fat absorption rate was significantly lower than that of chitosan alone (comparative group sentence and locust bean gum (comparative group 5)) in experimental group 3. This effect was shown by 20 statistical analysis, as Multiplication reduction effect (indicated by the mark * in the table). From the above facts, it can be seen that if the combination of (1) component and (2) component 25 200533300 of the present invention is combined, one person can achieve significant dietary fat absorption 丨And the effect is hindered. Among them, the combination of chitosan and Guanhua bean gum (Experiment 2)

吁)了達到特別強烈之效 果。如前述,(1)成分與(2)成分彳έΒ A 、 J战刀之組合可達到相乘之脂肪排 泄量增加作用。 5 實驗例3 I 了評估本發明組成物之阻鄕食脂肪吸收作用而進 行以下試驗。該實驗中,係使用大鼠作為被驗動物,並調 查被驗大鼠攝取組合有⑴幾丁聚畴與⑺關華豆膠之飼料 後對於血漿三酸甘油脂濃度所造成之影響。 10 1.被驗動物及飼育條# 被驗動物係使用雄性SD大鼠(9週齡,體重: 307〜342g)(購入來源:CLEA Japan,Inc.)22隻(6群X 4隻)。該 專被驗動物於試驗期間係個別收容於22Wx 29Wx 21H(cm) 之不鏽鋼製籠中,以溫度22〜24°C、濕度51〜60%及照明12 15小時(7時_丨9時)/日之條件下進行飼育。水則自由攝取自來 水。 k實驗方法及眚給鮮 以下述組成之含20%脂肪精製飼料飼育雄性SD大鼠1 週。飼料係於每日1〇:〇〇〜10:30及12:00〜17:00之間自由攝 20 取。1週後,將大鼠分成平均體重相等之本發明群及對照群 (本發明群10隻及對照群12隻)。 使各群大鼠自1〇:3〇起絕食一天,於翌日之 10:00〜10:3〇,將添加有幾丁聚醣lg/l〇〇g及關華豆膠3g/100g 來取代含20%脂肪之精製飼料中之纖維素4g/100g的飼料 26 200533300 (本發明飼料)4g給餌予本發明群之各大鼠。對照群之大鼠則 給予含2〇%脂肪之精製飼料4g。 <含20%脂肪之精製飼料(單位:g)> 10 酪蛋白 α -玉米澱粉 /3-玉米澱粉 蔗糖 大豆油 混合礦物質之ΑΙΝ93 混合維生素之ΑΙΝ93 L-半胱胺酸 丁基羥基醌 200 132 277.5 102.5 200 35 10 3 0.014 纖維素 合計 15 20 40 1000.014 此外,混合礦物質之ΑΙΝ93及混合維生素之八取93均使 用 Oriental Yeast Co.,ltd.製者。 3.測定項目及測定方法 於本發明飼料或含20%脂肪之精製飼料進彳-込 ^ 給餌開始1、2、3、4及6小時後之各時期,從 耳引及 靜脈採血並分離血漿,再使用市售之測定 大鼠之尾 三酿孙、、上Η匕 Ε-測試和光(Triglyceride E-Test Wako)TM · $ 〆月曰 Pure Chemical Industries,Ltd))測定該血漿中 未(waKo 量(mg/dL) ° 自飼料給餌起經過預定時間後之血默 酸甘油脂 甘油脂測定 27 200533300 值扣除給餌前之測定值,求出各經過時間之血漿三酸甘油 脂變化量(上升量,mg/dL)。求出之結果係以平均值±標準 誤差來表示。本發明群與對照群間之比較係以無對應之1檢 疋(SAS Version 8)進行。有意水準為兩側5%,並將危險率 5 5·0%以下判定為具有意差。 4.測定結舉 茲將結果示於第1圖(橫軸··給餌後時間(小時)、縱軸: 鲁血漿三酸甘油脂變化量(上升量)(mg/dL))。 圖中,(1)表示本發明群之結果,(2)表示對照群之結 W果。給_2小時後及3小時後之本發明群值之星號係表示相 對於對照群為有意義之較低值(p<〇〇5)。 由第1圖所示結果可明確得知,本發明群與對照群相較 下血漿三酸甘油脂量呈現有意義之較低值。據此,可知攝 取本發明組成物可阻礙膳食脂肪吸收。 15 實驗例4 • 為評估本發明組成物之阻礙膳食脂肪吸收作用而進行 以下實驗。該實驗中,係使大鼠持續攝取本發明組成物, 再以該持續攝取來調查大氛之糞中脂肪排泄量、脂肪組織 重量及肝臟三酸甘油脂量之經時變化。 20 k被驗動物及飼盲鉻杜 被驗動物係使用雄性SD大鼠(5週齡,體 重:137〜155§)(購入來源:(:1^八;叩奶,111(:)31隻(8隻><3群+ 7隻X 1群)。該等被驗動物之飼育條件除所用混餌飼料之種 類外係與實驗例3相同。 28 200533300 L實驗方法及眚赂# 飼料係使用下述各混餌飼料飼育28天(本發明群、比較 群1及2)。此外,對照群大鼠(n=8)則給予實驗例3所載組成 之含20%脂肪之精製飼料。 5 本發明群㈣):以幾丁聚醣原關華豆膠3%混_料 飼育:實驗例3所示組成之含20%脂肪之精製飼料中,將纖 維素40g/1000g取代為幾丁聚醣1〇g/1〇〇〇g及關華豆膠 30g/l〇〇〇g。 比較群l(n=7):以幾丁聚醣1%混餌飼料飼育:於實驗 10例3所示組成之含2〇°/。脂肪之精製飼料中,將纖維素4〇g中 之10g取代為幾丁聚_10g。 比較群2(n=8):以關華豆膠3%混餌飼料飼育:於實驗 例3所示組成之含20%脂肪之精製飼料中,將纖維素4〇g中 之30g取代為關華豆膠3〇g。 15 測定頊目及測定方法 自以混餌飼料飼育起之第24〜27曰的3天内,與實驗例1 相同地回收各群大鼠之糞便,並測定糞便中之總脂肪含量 (g/3日)。此外’同時測定糞便中之三酸甘油脂含量(mg/3日) 及遊離脂肪酸含量(μΕς/3曰)。 20 糞便中之三酸甘油脂含量係以Fletcher法(C7h. C/zim. 22, 393, 1968)測定。使以實驗例1所示Folch之方法而 獲得之粹取液(Folch粹取液)乾涸,將所得殘渣製為樣本, 再以市售之測定套組(NEFA C-測試和光™ (NEFA C-test wakoTM);和光純藥(Wako Pure Chemical Industries,Ltd))測 29 200533300 定糞便中之遊離脂肪酸含量。 此外’於飼育開始前與飼育期結束時,以電子天祥測 定各群大鼠之體重’算出體重增加量(Ag)。更於試驗期間 中,每曰測定各群大鼠之麟量,並算出其合計量(總攝辑 5量、g)。一曰之攝餌量係由給予各群大鼠之每曰飼料量扣 除當天殘留飼料量所得之值。由前述所得之體重增加量⑻ 及總攝斜量(F),依下式算出食辞效率⑼,飼料)。 食僻效率(g/l〇〇g飼料)=E+ Fx 1〇〇 更於飼育期結束後(帛28天)魏各群,測定肝臟重 π)量⑻及腎周圍脂肪組織重量(g),算出每1〇〇g體重之各臟号 重量(g/_體重)。此外,以Foleh氏等人之方法粹取脂肪 後’以Fletcher法(Clin. Chim. Acta,22,取 1968)測定肝臟 中之一日里(g) ’而异出每克肝臟之三酸甘油脂量 (g/g肝臟)。 15 祕結果係以平均值±標準差表示。各群間之比較係 以Tukey-K職er法進行(SAS Versi〇n 8)。有意水準為兩側 5%,並將危險率5.〇%以下視為具有有意差。 4 ·測定結果 兹將結果表示於下述表3、表4及第2圖。 2〇 I表所示數值右上方之英文字母係用以表示有無有意 差者,相異之英文字母表示具有有意差㈣〇5)。舉例言 之在效率中,標記在本發明群之值的b與對照群之值 (才丁己之值)相較下,顯不出有意差。此外,該值與比較群工 及比較群2之值(標記a,b之值)則未顯示出有意差。再者,比 30 200533300 較群1及比較群2之值與對照群之值相較下顯示出未具有意 差。同樣地,腎周圍脂肪組織重量中,本發明群之值(標記 c之值)相對於比較群i之值(標記b之值)、比較群2之值(標記 ab之值)及對照群之值(標記a之值)中之任一者均顯示出有 5意差(均為Ρ<0·〇5)。比較群1之該腎周圍脂肪組織重量係標 記b,如其所示,與比較群2之值(ab)對比下並無有意差,與 對照群之值(a)對比則可見有意差。比較群2之該腎周圍組織 重量係標記ab,如其所示,與對照群之值(a)對比係顯示出 無有意差。 10 表3 群 測定項目 本發明群 (n=8) 比較群1 (n=7) 比較群2 (n=8) 對照群 (n=8) 試驗開始前體重(g) 146.5 士 5.8 145.9±5.9 146.9±5.5 145·9±5·9 試驗終了時體重(g) 328.8士 36.4 344.9士 123 350.5土 12.4 355.2士 12.2 體重增加量(Ag) 182.3 土 36.4 199.0±11.0 203.6土 11.3 209.3±9.7 總攝1 耳量(g) 494.7士 55.4 494.6士10.2 509.3±13.0 512.0±12.4 食餌效率(g/100g飼料) 36.6±4.4b 40.2±1.8@ 40.0±2.0^ 40.9±1.7a 肝臟重量(g/l〇〇g體重) 2.8 士 0·2 3.0±0.2 2.7 土 0.1 2.8 士 0.2 腎周圍脂肪組織重量 (g/l〇〇g 體重) 1.2 士 0.4C 1.9 士 0.2b 2.0±0.4ab 2.4 士 0.4a(Call) to achieve a particularly strong effect. As mentioned above, the combination of the components (1) and (B), A, J, and Sabre can increase the fat excretion by multiplication. 5 Experimental Example 3 I The following tests were performed to evaluate the effect of the composition of the present invention on the effect of inhibiting the fat absorption of food. In this experiment, rats were used as the test animals, and the effects of ingestion of a diet combined with chitin chitin and Tongguanhua bean gum on plasma triglyceride concentrations were examined. 10 1. Test animals and breeding strips # The test animals used male SD rats (9 weeks old, weight: 307 ~ 342g) (purchased from: CLEA Japan, Inc.) 22 (6 groups X 4). The test animals were individually housed in stainless steel cages of 22Wx 29Wx 21H (cm) during the test period, with a temperature of 22 to 24 ° C, a humidity of 51 to 60%, and 12 hours of lighting for 12 hours (7 o'clock to 9 o'clock). / Day conditions. Water is free to tap water. kExperimental methods and freshwater feeding Male SD rats were fed a 20% fat-refined feed of the following composition for 1 week. The feed is taken freely from 10: 00 to 10: 30 and 12:00 to 17:00 20 times daily. After 1 week, the rats were divided into the present invention group and the control group (the present invention group was 10 and the control group was 12) having the same average weight. Rats of each group were fasted for a day from 10:30, and from 10:00 to 10:30 the next day, chitosan lg / 100g and Guanhua bean gum 3g / 100g were added instead. 4g / 100g of cellulose in a refined feed containing 20% fat 26 200533300 (Feed of the present invention) 4g was fed to each rat of the present group. Rats in the control group were given 4 g of refined feed containing 20% fat. < Refined feed with 20% fat (unit: g) > 10 Casein α-Corn Starch / 3-Corn Starch Sucrose Soybean Oil Mixed Minerals ΑΝΝ93 Mixed Vitamins ΑΙΝ93 L-cysteine butylhydroxyquinone 200 132 277.5 102.5 200 35 10 3 0.014 Total cellulose 15 20 40 1000.014 In addition, ΑΝΝ93 of mixed minerals and 取 93 of mixed vitamins were both manufactured by Oriental Yeast Co., ltd. 3. Measurement items and measurement methods In the feed of the present invention or refined feed containing 20% fat, 彳-込 ^ Blood is collected from ear leads and veins and separated from blood plasma at various periods of 1, 2, 3, 4 and 6 hours after the start of feeding. , And then use commercially available test rats Takamaki-san, Takilyceride E-Test WakoTM, and $ Chemicals Pure Chemical Industries, Ltd.) to determine Amount (mg / dL) ° Determination of glycerol and glycerol in blood after a predetermined period of time has elapsed since the feeding of the bait. 27 200533300 Subtract the measured value before feeding the bait. , Mg / dL). The results obtained are expressed as mean ± standard error. The comparison between the group of the present invention and the control group is carried out with a non-corresponding 1 test (SAS Version 8). The intentional level is 5 on both sides %, And the hazard rate was judged as having an error rate of 5 5.0% or less. 4. The measurement results are shown in Figure 1 (horizontal axis ·· time after feeding (hours), vertical axis: plasma triacid The amount of glycerolipid change (increased amount) (mg / dL). In the figure, (1) represents the present invention group As a result, (2) represents the results of the control group. The asterisks giving the group values of the present invention after _2 hours and 3 hours indicate lower values that are meaningful relative to the control group (p < 0.05). It is clear from the results shown in Figure 1 that the plasma triglyceride content of the present invention group is significantly lower than the control group. Based on this, it can be seen that ingestion of the composition of the present invention can hinder dietary fat absorption. 15 Experiments Example 4 • To evaluate the effect of the composition of the present invention on inhibiting the absorption of dietary fat, the following experiment was performed. In this experiment, rats were continuously ingested the composition of the present invention, and the continuous intake was used to investigate the amount of fat excretion in fecal atmosphere. , Adipose tissue weight and liver triglyceride content change over time. 20 k test animals and feeding blind chromium duo test animals used male SD rats (5 weeks old, weight: 137 ~ 155§) (purchased from : (: 1 ^ eight; milk, 111 (:) 31 (8 > < 3 groups + 7 X 1 group). The feeding conditions of these tested animals are different from the type of mixed bait feed used. Experimental example 3 is the same. 28 200533300 LExperiment method and 眚 brig # Feed system under the use Each mixed bait feed was bred for 28 days (inventive group, comparative groups 1 and 2). In addition, the control group of rats (n = 8) was given a refined feed containing 20% fat containing the composition contained in Experimental Example 3. 5 Inventive group ㈣): Chitosan original Guanhua bean gum 3% mixed feed: Feeding: In the refined feed containing 20% fat as shown in Experimental Example 3, 40g / 1000g of cellulose was replaced with chitosan1. g / 1000g and Guanhua bean gum 30g / 1000g. Comparative group 1 (n = 7): Breeding with chitosan 1% mixed bait feed: In experiment 10, the composition shown in Example 3 contained 20 ° /. In the fat-refined feed, 10 g of 40 g of cellulose was replaced with chitin 10 g. Comparative group 2 (n = 8): fed with Guanhua soybean gum 3% mixed bait feed: In a refined feed containing 20% fat containing the composition shown in Experimental Example 3, 30 g of 40 g of cellulose was replaced with Guan Hua 30 g of soy gum. 15 Determination of the order and measurement method Within 3 days from the 24th to the 27th day after breeding with mixed bait feed, the feces of each group of rats were recovered in the same manner as in Experimental Example 1, and the total fat content in the feces was measured (g / 3 days) ). In addition, the triglyceride content (mg / 3 days) and free fatty acid content (μΕς / 3) of feces were measured simultaneously. 20 Triglyceride content in feces was determined by the Fletcher method (C7h. C / zim. 22, 393, 1968). The Folch extract (Folch extract) obtained by the Folch method shown in Experimental Example 1 was dried, and the obtained residue was made into a sample, and then a commercially available measurement kit (NEFA C-Test and Light ™ (NEFA C- test wako (TM); Wako Pure Chemical Industries, Ltd.) measured 29 200533300 free fatty acid content in stool. In addition, "the body weight of each group of rats was measured by electronic celestial measurement before the start of the breeding period and the end of the breeding period" to calculate the weight gain (Ag). During the test period, the amount of rats in each group was measured every day, and the total amount was calculated (total volume 5 g). The daily feed intake is a value obtained by subtracting the amount of feed remaining on that day from the daily feed amount given to each group of rats. From the weight gain ⑻ and total tilt (F) obtained as described above, the lexical efficiency ⑼ (feed) is calculated according to the following formula. Food efficiency (g / 100g feed) = E + Fx 100 more than Wei group after the end of the breeding period (28 days), the amount of liver weight π) and the weight of adipose tissue around the kidney (g), Calculate the weight of each viscera per 100 g of body weight (g / _body weight). In addition, after taking fat according to the method of Foleh et al., "One day in the liver (g)" was measured by the Fletcher method (Clin. Chim. Acta, 22, 1968), and triglycerides per gram of liver were different. Fat (g / g liver). 15 Secret results are expressed as mean ± SD. The comparison between the groups was performed by the Tukey-Ker method (SAS Versión 8). The intentional level is 5% on both sides, and the hazard rate below 5.0% is considered to be intentional. 4 • Measurement results The results are shown in Tables 3, 4 and 2 below. The English letters in the upper right of the numerical values shown in Table I are used to indicate the presence or absence of intentional differences, and the different English letters indicate intentional differences (㈣05). For example, in terms of efficiency, the value b in the group of the present invention is compared with the value of the control group (the value of the group), and there is no intentional difference. In addition, this value and the value of the comparative group worker and the comparative group 2 (values of the marks a, b) did not show an intentional difference. Furthermore, the values of comparative group 1 and comparative group 2 compared with the values of control group than 30 200533300 showed no significant difference. Similarly, in the weight of adipose tissue around the kidney, the value of the group of the present invention (value of mark c) is compared with the value of comparison group i (value of mark b), the value of comparison group 2 (value of mark ab), and the value of the control group. Any one of the values (the value of the mark a) showed 5 meaning differences (both P < 0.05). In comparison group 1, the weight of the surrounding adipose tissue of the kidney is labeled b. As shown in the figure, there is no intentional difference compared with the value (ab) of comparative group 2, and the intentional difference is compared with the value (a) of the control group. The weight of the surrounding kidney tissue of the comparative group 2 is marked ab, and as shown, the comparison with the value (a) of the control group shows no intentional difference. 10 Table 3 Group measurement items The present invention group (n = 8) Comparative group 1 (n = 7) Comparative group 2 (n = 8) Control group (n = 8) Weight before the test (g) 146.5 ± 5.8 145.9 ± 5.9 146.9 ± 5.5 145 · 9 ± 5 · 9 Weight at the end of the test (g) 328.8 ± 36.4 344.9 ± 123 350.5 ± 12.4 355.2 ± 12.2. Weight gain (Ag) 182.3 ± 36.4 199.0 ± 11.0 203.6 ± 11.3 209.3 ± 9.7 Total photo 1 Ear volume (g) 494.7 ± 55.4 494.6 ± 10.2 509.3 ± 13.0 512.0 ± 12.4 Feed efficiency (g / 100g feed) 36.6 ± 4.4b 40.2 ± 1.8 @ 40.0 ± 2.0 ^ 40.9 ± 1.7a Liver weight (g / lO〇g Weight) 2.8 ± 0.2 3.0 ± 0.2 2.7 ± 0.1 2.8 ± 0.2 Weight of adipose tissue around the kidney (g / 100 g weight) 1.2 ± 0.4C 1.9 ± 0.2b 2.0 ± 0.4ab 2.4 ± 0.4a

表4 群 測定項目 本發明群 (n=8) 比較群1 (n=7) 比較群2 (n=8) 對照群 (n=8) 總脂肪(g/3曰間) 1.18士0.24c 0.62±0.23b 0.24士 0.05a 0.20±0.03a 三酸甘油脂(mg/3日間) 15.4±4.5C 10.6土 3.9b 4.2±2.9b 4.2±0.8a 遊離脂肪酸&Eq/3日間) 1357±434b 621士203a 337土 97a 317士 126a 由表3、表4及第2圖所示結果可確知如下事項。即,本 發明群之腎周圍脂肪組織重量與比較群丨、比較群2及對照 群相較下顯示出有意的較低值(參照表3)。就肝臟中之三酸 31 200533300 ▲ σ本發明群與比較群1、比較群2及對照群相 父,、有意義地顯示出較低值(參照第2圖)。此外,不論是 糞:之總脂肪排泄量、三酸甘油脂排泄量及遊離脂肪酸排 泄置,本發明群與比較群1、比較群2及對照群相較下均有 5意地顯示出較高值(表4⑹。 勾有 從上述事項可作出如下結論。 按本發明來組合攝取幾丁聚聽與關華豆膠,與單獨 攝取轉(比|父群丨及比較群2)相較下,顯示出顯著的阻礙膳 食脂肪吸收效果;及 1〇 (2)持續攝取本發明組成物與單獨攝取幾丁聚酷及關華 豆膠(比較群1及比較群2)相較下,可獲得體脂肪減低效果。 實驗例5 為評估本發明組成物之阻礙膳食脂肪吸收作用而進行 以下實驗。該實驗係選擇成人男性為被驗者,並調查該被 15驗者攝取本發明組成物對於血清三酸甘油脂值造成之影 響。 1.被驗者 被驗者係選擇成人男性(健康正常者)8名。該等被驗者 均未接受過包含高血脂症治療劑之投藥等的藥物治療。被 20 驗者之年齡在34歲至51歲之範圍(平均年齡:43± 2歲),體 重在58.7_116.0kg之範圍(平均體重:76·9± 6.3kg),BMI [體 重kg/(身長m)2]為20.4-38.5kg/m2之範圍(平均BMI : 36·0土 1.9kg/m2),血清三酸甘油脂值於i〇i_i81mg/D1之範圍(平 均:132± 10mg/dL),血清全膽固醇值於i59-294mg/dL之範 32 200533300 圍(平均:224± 16mg/dL)。 2.實驗方法 使被驗者在試驗2日前攝取下述之規定食物,並自試驗 前日起自試驗開始為止絕食約14小時。於試驗開始日僅口 5 服攝取下述組成之脂肪食物或於口服脂肪食物之同時口服 下述被驗物2g。試驗係以隔1週觀察期之交叉(Crossover)法 實施。 <規定食物> 第一天: 10 早餐:Caloriemate Block(大塚製藥株式會社製)4條 (400kcal) 午餐:便當A 晚餐:便當B 第二天: 15 早餐:Caloriemate Block(大塚製藥株式會社製)4條 (400kcal) 午食:便當A 晚餐:散壽司 <脂肪食物> 20 玉米奶油濃湯 200g 奶油 19g 豬油 15g 總熱量 438kcal 脂肪 40.4g 33 200533300 碳水化合物 14.8g 蛋白質 3.8g 灰分 2.1g <被驗物> 5 關華豆膠與幾丁聚醣之混合物顆粒(關華豆膠:幾丁聚 醣=3:1重量比)。 該顆粒係以如下方法製得。即,將由食品用幾丁聚醣 23份、滋耶(昭和產業社製,來自玉米之蛋白質)4_1份及中 鏈脂肪酸三酸甘油脂0.4份所構成之粉末混合物以流動層 10 造粒法進行製作。於其中加入關華豆膠72.5份與適量之水 加以混合,而製得顆粒用材料。將該材料擠壓造粒而製出 顆粒,並以棚式真空乾燥機乾燥後,分包而製為被驗物。 於試驗開始(攝取脂肪食物)前以及從開始攝取脂肪食 物起1、2、3、4及6小時後,自被驗者採血,並以酵素法測定 15 血清三酸甘油脂濃度,描繪出血清三酸甘油脂濃度曲線。 所得結果係以平均值±標準差表示。各群間之比較係 以有對應之t檢定進行(SAS Version 8)。有意水準為兩側 5%,並將危險率5.0%以下視為具有有意差。 3 ·測定結果 20 茲將所求出之血清三酸甘油脂濃度之結果顯示於第3 圖(縱軸:血清三酸甘油脂濃度(mg/dL),橫軸:攝取脂肪食 物後之時間(小時))。 圖中,各曲線係表示以下之群。 0 :對照群(非投予被驗物群) 34 200533300 2 :本發明群(同時投予被驗物2g與脂肪食物之群) 於第3圖中,攝取脂肪食物後時間之3小時,本發明群 (2)之生號係表示该群之血清三酸甘油脂濃度值相對於同時 間之對照群⑼之值呈現有意義之較低值(p<〇 〇5)。 5 由弟3圖所示結果可知,本發明群(2)與對照群(〇)相較 下,攝取脂肪食後之血清三酸甘油脂濃度於任何時間均顯 示較低值。據此,可知攝取本發明組成物可達成阻礙膳食 脂肪吸收之效果。 茲將本發明之用以阻礙膳食脂肪吸收之組成物的具體 10 的樣悲顯不為實施例。 實施例1-5 錠劑形態之調製 將表6所示各成分混合成預定比例(%),並將所得混合 物500g以直接粉末壓縮法成形為鍵劑形態,製得約 15 750〜25⑼個(每旋200-650mg)之本發明組成物。 35 200533300 表5 原料 實施例 實施例 實施例 實施例 實施例 1 2 3 4 5 幾丁聚醣 20 13 15 18 9 關華豆膠 60 40 果膠 46 刺槐_SL膠 54 刺雲實膠 36 乳糖 6 7 10 微結晶纖維素 10 43 20 15 40 玉米澱粉 17 甘油脂肪酸酯 4 4 蔗糖脂肪酸酯 3 2 植物油脂 5 微粒二氧化矽 1 1 1 1 1 總量(mg) 200 300 650 250 320Table 4 Group measurement items The present invention group (n = 8) Comparative group 1 (n = 7) Comparative group 2 (n = 8) Control group (n = 8) Total fat (g / 3 day) 1.18 ± 0.24c 0.62 ± 0.23b 0.24 ± 0.05a 0.20 ± 0.03a triglyceride (mg / 3 daytime) 15.4 ± 4.5C 10.6 soil 3.9b 4.2 ± 2.9b 4.2 ± 0.8a free fatty acid & Eq / 3 daytime) 1357 ± 434b 621 Taxi 203a 337 Soil 97a 317 Taxi 126a From the results shown in Table 3, Table 4 and Figure 2, the following matters can be confirmed. That is, the weight of adipose tissue around the kidneys of the present group showed a deliberately lower value than that of the comparative group, the comparative group 2, and the control group (see Table 3). Regarding the tris acid in the liver 31 200533300 ▲ σ The present invention group shows a relatively low value in comparison with the comparison group 1, the comparison group 2 and the control group (see Fig. 2). In addition, both the total fat excretion amount, triglyceride excretion amount, and free fatty acid excretion amount of feces: the present invention group and the comparison group 1, the comparison group 2 and the control group all showed a deliberately higher value than the comparison group 5 (Table 4⑹. From the above, the following conclusions can be drawn. According to the present invention, the combined intake of chitin and guanhua bean gum is compared with the individual intake conversion (comparison | parent group 丨 and comparative group 2). Exhibit significant obstructive effects on dietary fat absorption; and 10 (2) continuous intake of the composition of the present invention compared with the ingestion of chitin and Kuhua bean gum (Comparative Group 1 and Comparative Group 2) alone, body fat can be obtained Experiment 5 In order to evaluate the effect of the composition of the present invention on obstructing the absorption of dietary fat, the following experiment was performed. This experiment selected an adult male as the subject, and investigated that the 15 subjects ingested the composition of the present invention for serum triacid Effect of glycerol lipid value. 1. Subjects Subjects selected 8 adult males (normal healthy persons). None of these subjects had received any medical treatment including administration of hyperlipidemia therapeutic agents. 20 Subject age is 34 The age range is from 51 to 51 years (average age: 43 ± 2 years), the weight is in the range of 58.7_116.0 kg (average weight: 76 · 9 ± 6.3 kg), and the BMI [weight kg / (length m) 2] is 20.4- In the range of 38.5kg / m2 (average BMI: 36 · 0 to 1.9kg / m2), the serum triglyceride fat value is in the range of i0i_i81mg / D1 (average: 132 ± 10mg / dL), and the serum total cholesterol value is in i59 -294mg / dL range 32 200533300 (average: 224 ± 16mg / dL) 2. Experimental method Subjects ingest the following specified food before the 2nd day of the test, and go on a hunger strike for about 14 from the day before the test Hours. On the start day of the test, only 5 servings of fatty foods with the following composition were taken or 2g of the following test substance was taken orally at the same time as oral fat foods. The test was conducted by the Crossover method with an observation period of 1 week. Prescribed foods> Day 1: 10 Breakfast: Caloriemate Block (manufactured by Otsuka Pharmaceutical Co., Ltd.) 4 (400kcal) Lunch: Bento A Dinner: Bento B Day 2: 15 Breakfast: Caloriemate Block (manufactured by Otsuka Pharmaceutical Co., Ltd.) 4 Bar (400kcal) Lunch: Bento A Dinner: Casual Sushi < Fat Food > 20 Corn Cream 200g thick soup 19g lard 15g total calories 438kcal fat 40.4g 33 200533300 carbohydrate 14.8g protein 3.8g ash 2.1g < test substance > 5 granules of mixture of Guanhua bean gum and chitosan (guanhua bean Gum: Chitosan = 3: 1 weight ratio). The particles were prepared as follows. That is, a powder mixture consisting of 23 parts of chitosan for food, 4_1 parts of Shiya (produced by Showa Sangyo Co., Ltd., corn-derived protein) and 0.4 parts of medium-chain fatty acid triglyceride was carried out by a fluidized layer 10 granulation method. Production. 72.5 parts of Guanhua Bean Gum was mixed with an appropriate amount of water to prepare a material for granules. The material was extruded and granulated to produce granules, which were dried in a shed vacuum dryer, and then subcontracted to produce a test object. Before the start of the test (intake of fatty foods) and 1, 2, 3, 4 and 6 hours from the start of ingestion of fatty foods, blood was collected from the subjects, and the 15 serum triglyceride concentration was measured by the enzyme method, and the serum was plotted. Triglyceride concentration curve. The results obtained are expressed as mean ± standard deviation. Comparisons between groups were made with corresponding t-tests (SAS Version 8). The intentional level is 5% on both sides, and a hazard rate of 5.0% or less is considered intentional. 3. Measurement result 20 The results of the obtained serum triglyceride concentration are shown in Fig. 3 (vertical axis: serum triglyceride concentration (mg / dL), horizontal axis: time after ingesting fatty food ( hour)). In the figure, each curve indicates the following groups. 0: Control group (non-administered test subject group) 34 200533300 2: The present invention group (administered 2g test subject and fat food group at the same time) In Figure 3, 3 hours after ingestion of fat food, this group The birth number of the invention group (2) indicates that the serum triglyceride concentration value of this group showed a significant lower value than the value of the control group ⑼ at the same time (p < 005). 5 From the results shown in Figure 3, it can be seen that the serum triglyceride concentration of the present invention group (2) and the control group (0) showed a lower value at any time after ingestion of fatty food. Based on this, it was found that ingestion of the composition of the present invention can achieve the effect of inhibiting the absorption of dietary fat. The specific aspect of the composition for blocking dietary fat absorption of the present invention is not shown as an example. Example 1-5 Preparation of tablet form The ingredients shown in Table 6 were mixed into a predetermined ratio (%), and 500 g of the obtained mixture was formed into a bond form by a direct powder compression method to obtain about 15 750 to 25 ⑼ ( 200-650 mg per spin) of the composition of the present invention. 35 200533300 Table 5 Examples of raw materials Example Examples Example Examples 1 2 3 4 5 Chitosan 20 13 15 18 9 Guanhua Bean Gum 60 40 Pectin 46 Locust _SL Gum 54 Gum Cloud 36 Lactose 6 7 10 Microcrystalline cellulose 10 43 20 15 40 Corn starch 17 Glycerin fatty acid esters 4 4 Sucrose fatty acid esters 3 2 Vegetable fats and oils 5 Microparticles of silica 1 1 1 1 1 Total (mg) 200 300 650 250 320

實施例6 薄脆餅之調製 5 使用適量之水將關華豆膠4份、食品用幾丁聚醣1份、 小麥粉70份、砂糖5份、油脂12份以及適量之膨漲:劑、少量 食鹽及香料混合,製得薄脆餅材料。使該材料成型為適當 大小後,以180°C烤箱烤約10分鐘,而製得薄脆餅形態之本 發明組成物。 10 實施例7 硬餅乾之調製 使用適量之水將將刺槐豆膠3份、食品用幾丁聚醣1 份、小麥粉70份、砂糖13份、油脂10份、適量膨漲劑及香 料混合,製得硬餅乾材料。使該材料成型為適當大小後, 36 200533300 以180°C烤箱烤約l〇分鐘’而製得硬餅乾形態之本發明組成 物。 實施例8 牛奶糖之調製 5 將果膠5份、食品用幾丁聚醣1份、糖類30份及加糖練 乳30份懸濁於適量水中,調製出a液。另外,於油脂類5份 中加入適量乳化劑並加溫熔解,調製出B液。於A液中加入 B液,於加溫下均質化調製成乳化液後,一直煮至該乳化液 到達預定水分量為止。冷卻後,加入翻糖(f〇ndant)10份及 10適量香料等,以捏合機混合攪拌。使拌勻後之牛奶糖材料 成形成適當大小,而製得牛奶糖形態之本發明組成物。 實施例9 玉米濃湯之調製 將關華豆膠1份及食品用幾丁聚醣〇·2份懸濁於牛奶75 15份中。將該懸濁液與玉米(水煮)20份及調味料混合並實施濕 式粉碎後’加熱殺菌而製得玉米濃湯形態之本發明組成物。 會施例10及11 高蛋白流動食品形態之調製 使用預定比例(◦/〇)之表6所示各成分以調製本發明組成 20 物。 37 200533300 表6 實施例No. 實施例10 實施例11 幾丁聚醣 0.1 0.5 關華豆膠 0.5 — 果膠 — 1.5 絡蛋白 6.9 6.7 酿蛋白鈉 — 2.2 酪蛋白鈣 3.3 3.3 全脂奶粉 3.9 — 脫脂奶粉 1.5 — 明膠 — 1.4 酵素分解明膠 2.2 — 起司 2.0 — 精製白糖 2.7 3.0 米油 — 5.0 NaOH 0.1 0.1 MgS〇4 0.1 0.1 CaCl2 0.1 0.1 脂溶性維生素類 適量 適量 水溶性維生素類 適量 適量 香料 適量 適量Example 6 Preparation of crackers 5 Using appropriate amount of water, 4 parts of Guanhua bean gum, 1 part of chitosan for food, 70 parts of wheat flour, 5 parts of sugar, 12 parts of fat, and appropriate amount of swelling: agent, small amount Salt and spices are mixed to make a cracker material. After the material is formed into an appropriate size, it is baked in an oven at 180 ° C for about 10 minutes to obtain a composition of the present invention in the form of a wafer. 10 Example 7 Preparation of hard biscuits Using an appropriate amount of water, 3 parts of locust bean gum, 1 part of chitosan for food, 70 parts of wheat flour, 13 parts of sugar, 10 parts of fat, and appropriate amount of bulking agent and flavor are mixed. Made of hard biscuit material. After the material is formed into an appropriate size, 36 200533300 is baked in an oven at 180 ° C for about 10 minutes' to obtain a composition of the present invention in the form of a hard cookie. Example 8 Preparation of milk sugar 5 5 parts of pectin, 1 part of chitosan for food, 30 parts of sugar and 30 parts of sweetened milk were suspended in an appropriate amount of water to prepare a solution. In addition, an appropriate amount of an emulsifier was added to 5 parts of oils and fats, and the mixture was heated and melted to prepare a liquid B. Add liquid B to liquid A, homogenize and prepare an emulsion under heating, and cook until the emulsion reaches a predetermined moisture content. After cooling, 10 parts of fondant and 10 appropriate amount of spices were added, and the mixture was stirred with a kneader. The milk sugar material after mixing is formed into an appropriate size to obtain the composition of the present invention in the form of milk sugar. Example 9 Preparation of corn thick soup 1 part of Guanhua bean gum and 0.2 parts of chitosan for food were suspended in 75 parts of milk. This suspension was mixed with 20 parts of corn (boiled) and seasonings, and wet-pulverized, and then heat-sterilized to obtain a composition of the present invention in the form of a corn soup. Examples 10 and 11 Modification of the form of high-protein flowing foods Each component shown in Table 6 in a predetermined ratio (◦ / 〇) was used to prepare the composition 20 of the present invention. 37 200533300 Table 6 Example No. Example 10 Example 11 Chitosan 0.1 0.5 Guanhua Bean Gum 0.5 — Pectin — 1.5 Complex Protein 6.9 6.7 Sodium Protein — 2.2 Casein Calcium 3.3 3.3 Whole Milk Powder 3.9 — Skim Milk powder 1.5 — Gelatin — 1.4 Enzyme-degraded gelatin 2.2 — Cheese 2.0 — Refined white sugar 2.7 3.0 m oil — 5.0 NaOH 0.1 0.1 MgS〇4 0.1 0.1 CaCl2 0.1 0.1 Fat soluble vitamins moderate amount Water soluble vitamins moderate amount Flavor appropriate amount

即,將酪蛋白鈉、酪蛋白鈣、明膠、酵素分解明膠及 起司(蛋白質成分)以及糖類(精製白糖)投入水中,攪拌溶解 5 後,更於混合液中投入幾丁聚醣與關華豆膠(或果膠)以及適 量食鹽,攪拌溶解製成液狀物(A液)。另外,將酪蛋白投入 水中,加入NaOH使其中和溶解後,再加入全脂奶粉、脫脂 奶粉、MgS04、CaCl2、脂溶性維生素類及米油,攪拌溶解 而製成液狀物(B液)。混合所得A液與B液,攪拌後調整液 10 量,再加入水溶性維生素類及香料進行乳化,並將乳化物 38 200533300 填充在8GmL容量管狀容器,再進行殺g,而製得高蛋白流 動食品形態之本發明組成物。 實施例12 凍狀飲料形態 、,:果及艮口口用幾丁聚糖0_2份與適量砂糖、酸味 料香料(加/jnL/合解,將所得液體加熱殺菌後充填於紹 猪袋中,而製得綠飲料形態之本發明組成物。 實施例13That is, sodium caseinate, calcium caseinate, gelatin, enzyme-degraded gelatin, cheese (protein component) and sugars (refined white sugar) were put into water, stirred and dissolved for 5 times, and then chitosan and Guanhua were added to the mixture Bean gum (or pectin) and an appropriate amount of salt are stirred and dissolved to form a liquid (liquid A). In addition, casein was added to water, and NaOH was added to neutralize and dissolve. Then, whole milk powder, skimmed milk powder, MgS04, CaCl2, fat-soluble vitamins, and rice oil were added, and the mixture was stirred and dissolved to prepare a liquid (liquid B). Mix the obtained liquid A and liquid B, adjust the amount of liquid 10 after stirring, then add water-soluble vitamins and flavors to emulsify, and fill the emulsion 38 200533300 in a 8GmL capacity tubular container, and then kill the g to produce a high protein flow. The composition of the present invention in the form of food. Example 12: The shape of frozen beverages: 0_2 parts of chitosan and appropriate sugar and sour flavor (plus / jnL / combined solution), and the obtained liquid was heated and sterilized and filled into Shao pig bags. The composition of the present invention was obtained in the form of a green beverage.

顆粒之調製 10 冑關華旦膠75份、食品用幾丁聚醣25份加入適量之水 並混合,製得顆粒材料。將該材料擠壓造粒成形後,再乾 燥而製得顆粒形態之本發明組成物。 產業上之可利用性 本發明係提供一種可達成優異之脂肪蓄積阻礙作用 15 (脂肪吸收阻礙作用)之組成物,該組成物作為機能性製劑及 飲食品係甚為有用。 【圖式簡單說明】 第1圖係一顯示實驗例3之試驗結果之曲線圖(橫軸:給 僻後時間(小時)、縱軸:血裂三酸甘油脂濃度(mg/dL))。 20 第2圖係一顯示實驗例4之試驗結果之長條圖(縱軸:肝 臟三酸甘油脂量(mg/g肝臟)。 第3圖係一曲線圖,顯示依實驗例5所示試驗所求出血 清三酸甘油脂濃度之結果(橫軸:脂肪食攝取後時間(時 間)、縱軸:血清三酸甘油脂濃度(mg/dL))。 39 200533300 【主要元件符號說明】(無)Preparation of granules 10 Tongguan Huadan Gum, 75 parts of chitosan for food, add an appropriate amount of water and mix to obtain a granular material. The material is extruded and granulated, and then dried to obtain the composition of the present invention in the form of particles. Industrial Applicability The present invention provides a composition capable of achieving an excellent fat accumulation inhibiting effect 15 (fat absorption inhibiting effect). The composition is useful as a functional preparation and a food and beverage product. [Brief description of the figure] Figure 1 is a graph showing the test results of Experimental Example 3 (horizontal axis: time after withdrawal (hours), vertical axis: triglyceride concentration (mg / dL)). 20 Figure 2 is a bar graph showing the test results of Experimental Example 4 (vertical axis: liver triglyceride amount (mg / g liver). Figure 3 is a graph showing the test according to Experimental Example 5 Result of the obtained serum triglyceride concentration (horizontal axis: time (time) after ingestion of fatty food, vertical axis: serum triglyceride concentration (mg / dL)). 39 200533300 [Explanation of Symbols of Main Components] (No )

4040

Claims (1)

200533300 十、申請專利範圍: 1. -種用以阻礙膳食脂肪吸收之組成物,含有:⑴幾丁聚 醣;及⑺水溶性食物纖維,係選自於由關華豆膠(Guar G·)、果膠(—η)、刺雲實膠(Tara Gum)及刺槐豆膠 5 Gum)所構成群組中之至少丨種。 少 2. 如申請專利範圍第^“阻鄕食賴吸收之 物’其中該水紐食物纖維係選自於㈣華豆膠、果取 及刺槐豆膠所構成群組中之至少丨種。 夕 3. 如申請專利範圍第1項之“阻礙腾食賴吸收之技成 10 物,其中該水溶性食物纖維為關華豆膠。 4·如申請專利範圍第1項之用以阻礙膳食脂肪吸收之叙成 物,其相對於所含⑴幾丁聚m重量份,係以M0重量 份之比例含有⑺水溶性食物纖維,且該水溶性食物纖維 係選自於由關華立膠、果膠、刺雲實膠及刺槐豆膠所構 15 成群組中之至少1種。 5. 如申請專利範圍第1項之用以阻礙膳食脂肪吸收之繞成 物,其相對於所含(1)幾丁聚醣丨重量份,係以3_7重量份 之比例含有(2)水溶性食物、織維’且該水溶性食物纖維係 選自於由關華丑膠、果膠、刺雲實膠及刺槐豆膠所構成 20 群組中之至少1種。 6, 如申請專利範圍第3項之用以阻礙膳食麟吸收之組成 物,其相對於所含(1)幾丁聚醣丨重量份,係以3_7重量份 之比例含有Ο關華丑勝。 7·如申請專利範圍第1項之用以阻礙膳食脂肪吸收之組成 41 200533300 物’其係呈現一適於經口投予之形態。 8.如申請專利範圍第1項之用以阻礙膳食脂肪吸收之組成 物,其係具有一飲食品形態,且該飲食品之形態係選自 於由點心、飲料以及補給品(supplement)所構成之群組。 5 9· 一種於需要阻礙膳食脂肪吸收之人體内阻礙膳食脂肪 吸收之方法,係使該人體經口攝取有效量之申請專利範 圍弟1項之組成物者。 10· —種於需要膳食脂肪排出體外之人體中使膳食脂肪排 出體外之方法,係使該人體經口攝取有效量之申請專利 10 範圍弟1項之組成物者。。 11· 一種需要抗肥胖之人體之抗肥胖方法,係使該人體經口 攝取有效量之申請專利範圍第1項之組成物者。 12· —種申請專利範圍第1項之組成物之用途,係使該組成 物用以阻礙膳食脂肪吸收者。 15 13· 一種申請專利範圍第1項之組成物之用途,係使該組成 物用以使膳食脂肪排出體外者。 14. 一種申請專利範圍第1項之組成物之用途,係使該組成 物用以抗肥胖者。 15· —種(1)幾丁聚醣及(幻水溶性食物纖維之用途,係使該 20 等用以製造申請專利範圍第1項之組成物者,其中該水 溶性食物纖維係選自由關華豆膠、果膠、刺雲實膠及刺 槐丑膠所構成之群組中之至少1種。 42200533300 X. Scope of patent application: 1.-a composition for hindering the absorption of dietary fat, containing: chitosan; and ⑺ water-soluble dietary fiber, which is selected from Guar G · , Pectin (-η), Tara Gum, and Locust Bean Gum 5 Gum). Less 2. For example, the scope of the application for patent ^ "Materials that inhibit the absorption of food and food", wherein the water button dietary fiber is at least one selected from the group consisting of Lihua bean gum, fruit extract, and locust bean gum. 3. For example, in the patent application, item 1 "Techniques that hinder the absorption of Teng Shi Lai into 10 products, in which the water-soluble dietary fiber is Guanhua bean gum. 4. As described in item 1 of the scope of the patent application, which is used to hinder the absorption of dietary fat, it contains ⑺ water-soluble dietary fiber in a proportion of M0 parts by weight with respect to m parts by weight of ⑴Chitin. The water-soluble dietary fiber is at least one selected from the group consisting of Guanhuali gum, pectin, ganoderma gum, and locust bean gum. 5. For example, the winding for obstructing the absorption of dietary fat in item 1 of the scope of patent application, which contains 3 to 7 parts by weight with respect to the contained (1) chitosan 丨 parts by weight (2) water-soluble Food, weaving, and the water-soluble dietary fiber is at least one member selected from the group consisting of Guanhua ugly gum, pectin, thorn cloud gum, and locust bean gum. 6. For example, the composition for blocking dietary lin absorption in item 3 of the scope of patent application contains 3 to 7 parts by weight of Guanhua Chousheng with respect to (1) parts by weight of chitosan. 7. The composition for obstructing the absorption of dietary fat according to item 1 of the scope of patent application 41 200533300 The substance 'presents a form suitable for oral administration. 8. The composition for blocking the absorption of dietary fat according to item 1 of the scope of patent application, which has a form of food and drink, and the form of the food and drink is selected from the group consisting of snacks, beverages, and supplements Group. 5 9 · A method for hindering the absorption of dietary fat in a person who needs to block the absorption of dietary fat, is to make the human body orally ingest an effective amount of the composition in the scope of patent application No. 1. 10 · —A method for excreting dietary fat in a human body that requires dietary fat to be excreted from the body, which is a composition for which the human body ingests an effective amount of a patent claim 1 item. . 11. An anti-obesity method for a human body in need of anti-obesity, which is to make the human body orally ingest an effective amount of the composition in the scope of patent application item 1. 12. Use of the composition of the scope of patent application No. 1 is for those who use the composition to hinder the absorption of dietary fat. 15 13 · A use of the composition in the scope of patent application No. 1 is for the use of the composition to excrete dietary fat from the body. 14. A use of the composition of claim 1 in the scope of patent application is to use the composition for anti-obesity. 15 · —Species (1) The use of chitosan and (magic water-soluble dietary fiber) is to use the 20 and other components to manufacture the composition of the first patent application scope, wherein the water-soluble dietary fiber is selected from At least one of the group consisting of Chinese bean gum, pectin, thorn cloud gum, and locust ugly gum. 42
TW094102271A 2004-01-30 2005-01-26 Composition for inhibting dietary lipid absorption TW200533300A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004022983 2004-01-30

Publications (1)

Publication Number Publication Date
TW200533300A true TW200533300A (en) 2005-10-16

Family

ID=34823858

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094102271A TW200533300A (en) 2004-01-30 2005-01-26 Composition for inhibting dietary lipid absorption

Country Status (2)

Country Link
TW (1) TW200533300A (en)
WO (1) WO2005072750A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6032662B2 (en) * 2009-09-17 2016-11-30 国立大学法人 千葉大学 Composition for inhibiting fat accumulation

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2944675B2 (en) * 1989-02-28 1999-09-06 大日本製薬株式会社 Lipid lowering agent and bowel movement improving agent
JP2920382B2 (en) * 1989-04-17 1999-07-19 株式会社ニチロ Separation method of components such as fruit juice, separated useful ingredient substance, and method of producing separated useful ingredient substance
JP2983716B2 (en) * 1991-09-27 1999-11-29 雪印乳業株式会社 Food composition comprising a water-soluble dietary fiber complex
JPH0987302A (en) * 1995-09-22 1997-03-31 Toto Ltd Composition containing chitosan
JPH09241169A (en) * 1996-03-04 1997-09-16 Susumu Kawashima Gel state composition having compound releasing and adsorbing property
US6200574B1 (en) * 1996-07-08 2001-03-13 Jose A. Diaz Chemical composition for aiding the absorption, binding and elimination of undigested fat
JP3108675B2 (en) * 1998-03-17 2000-11-13 阪急共栄物産株式会社 Lipid metabolism improver
EP1105144A4 (en) * 1998-08-18 2003-05-21 Jose A Diaz Composition and method for eliminating undigested fat and reducing cholesterol in the human body
JP2001120227A (en) * 1999-10-29 2001-05-08 We'll Corporation:Kk Diet food
JP4215377B2 (en) * 2000-05-01 2009-01-28 小林製薬株式会社 Chitosan-containing composition
JP2003199534A (en) * 2002-01-05 2003-07-15 Nihon Shokken Co Ltd Food or drink containing middle molecular pectin having lipase activity-inhibiting action
JP3972191B2 (en) * 2002-06-17 2007-09-05 大塚製薬株式会社 Dioxin excretion promoting composition
JP4460234B2 (en) * 2003-07-03 2010-05-12 株式会社東洋新薬 Diet food

Also Published As

Publication number Publication date
WO2005072750A1 (en) 2005-08-11

Similar Documents

Publication Publication Date Title
CA2876460C (en) Dietary supplement and methods of use
CA2878005C (en) Composition and use of a formulation to increase the ratio of gastrointestinal microbiota in phylum bacteriodetes to microbiota of firmicutes phylum
US20080003265A1 (en) Protein and fiber containing dietary supplement
US20110177175A1 (en) Dietary fiber compositions
JP2006508057A (en) Nutritional composition comprising non-glucose carbohydrate or pectin and soluble fiber
JP2017514521A (en) Food, system, method and kit for providing electrolyte replenishment
WO2013142424A1 (en) Beta-hydroxy-beta-methylbutyric acid for improving glucose tolerance
JP2009286703A (en) Body fat accumulation-improving agent and metabolic syndrome-improving agent containing d-tagatose as active ingredient
US20200214330A1 (en) Rice protein hydrolysates with anti-inflammatory properties
JP2008266223A (en) Formulation for ameliorating excessive sensitivity to cold
KR20200016608A (en) The health food composition for regulating weight
CA2548379C (en) Compositions of galactomannan for the treatment of bowel diseases
JP4889970B2 (en) Hyperphosphatemia preparation
JP2003113089A (en) Chitosan-containing formulation having action to inhibit lipid accumulation and reduce cholesterol and food and drink
KR20060024766A (en) Food for improving clinical conditions capable of lowering the concentration of low-molecular weight nitrogen-containing compounds in blood
JP3807464B2 (en) Anti-obesity agent
TW200533300A (en) Composition for inhibting dietary lipid absorption
JP3972191B2 (en) Dioxin excretion promoting composition
JP2020127392A (en) Intestinal function-controlling medicine containing inulin
CN109221903A (en) A kind of auxiliary defaecation and the meal replacement powder of norcholesterol and its preparation method and application
JP2012188426A (en) Lipid metabolism-improving composition
US20130034645A1 (en) Functional food composition and its use in diet food
AU2014262248B2 (en) Dietary fiber composition comprising glucomannan, xanthan gum, alginate and lipid
JP5008910B2 (en) Composition for improving lipid metabolism
JP2667351C (en)